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BIOPHYSICAL STUDIES OF MOTIONS AND INTERACTIONS OF MEMBRANE 
PROTEINS 
 We have utilized a variety of biophysical techniques to quantitatively examine the 
motions and interactions of transmembrane proteins on living cells at the single-molecule level. 
These include both widefield and confocal optical microscopic methods such as single particle 
tracking, Förster resonance energy transfer and ratiometric imaging of phase-sensitive probes of 
lipid order, together with spectroscopic fluctuation methods such as fluorescence correlation 
spectroscopy and photon counting histogram analysis. Our studies indicate that; 1. Luteinizing 
hormone receptors on CHO cells and KGN human granulosa cells exhibit restricted lateral 
diffusion and increased self-association after exposure to human chorianic gonadotropin; 2. In 
addition to insulin receptor and IGF1 receptor homodimers, rat basophilic leukemia 2H3 cells 
express significant levels of insulin receptor-IGF1 receptor heterodimers; 3. Clustering of insulin 
receptors after exposure to insulin on rat basophilic leukemia 2H3 cells is affected by disruption 
of actin-filaments but not by extraction of membrane cholesterol; 4. Chromium Picolinate and 
Bis(maltolato)oxovandium(IV) both restrict the lateral diffusion of insulin receptors on rat 
basophilic leukemia cells and; 5. Individual Fcε receptors on rat basophilic leukemia cells exhibit 
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BIOPHYSICAL STUDIES OF MOTIONS AND INTERACTIONS OF MEMBRANE 
PROTEINS 
 We have utilized a variety of biophysical techniques to quantitatively examine the 
motions, interactions and local environments of transmembrane proteins on living cells at the 
single-molecule level. These include both widefield and confocal optical microscopic methods 
such as single particle tracking, Förster resonance energy transfer and ratiometric imaging of 
phase-sensitive probes of lipid order, together with spectroscopic fluctuation methods such as 
fluorescence correlation spectroscopy and photon counting histogram analysis.  
 The quantitative examination of the motions, interactions and local environment of 
membrane proteins, particularly transmembrane receptor proteins, is of considerable interest to 
both scientists and medical professionals.  Since the introduction of the fluid mosaic model 
describing biological membranes by Singer and Nicolson in the early 1970’s [1], which built on 
the work of Frye and Edidin [2] and of Loor et al. [3], it has become evident that changes in the 
motions and interactions of membrane-localized proteins in response to extracellular or 
cytoplasmic chemical species significantly affects the behavior of live cells.  
Increased interest in the complex and heterogeneous composition of biological 
membranes has followed. Originally proposed by Simons and Ikonen [4], the “lipid raft” 
hypothesis suggests that certain lipids and amphipathic molecules self-associate in biological 
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membranes creating a variety of both highly transient and semi-permanent membrane 
structures of differing size and composition. More recently, it has been established that, in 
addition to the effects of lipid-delineated structures such as lipid rafts, the behavior of membrane-
localized proteins is also regulated by cytoskeletal structures such as actin filaments [5]. These 
subsurfaceactin and actin-associated protein structures compartmentalize membrane proteins such 
as transmembrane receptors.  
Lateral segregation of membrane proteins, such as transmembrane protein receptors, 
within both lipid and cytoskeletal delineated membrane structures has been shown to play a 
significant role in the regulation of cell signaling events. This appears to arise from the increased 
likelihood of receptor aggregation or interactions with other membrane localized species while 
confined within such structures. Binding of ligands or other regulatory molecules along with 
compositional changes in the membrane itself often initiate changes in the motions and 
interactions of membrane proteins such as transmembrane receptor proteins. 
 Herein, we describe the application of both microscopic and spectroscopic biophysical 
methods to quantitate the effects of ligand binding and membrane composition on the motions 
and interactions of several transmembrane receptor proteins. Often it is only with biophysical 
methods such as these that meaningful information regarding dynamics of individual molecules 
on living cells can be obtained. Our studies indicate that luteinizing hormone receptors, insulin 
receptors, insulin-like growth factor one receptors and the high affinity IgE receptor all exhibit 
significant changes in either their motions or interactions with other lipids and proteins after 
exposure to receptor-specific ligands or to reagents that alter membrane composition. 
[1] S.J. Singer and G.L. Nicolson, The fluid mosaic model of the structure of cell 
membranes.  Cell membranes are viewed as two-dimensional solutions of oriented 
globular proteins and lipids Science 175 (1972) 720-731. 
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[2] L.D. Frye and M. Edidin, The rapid intermixing of cell surface antigens after formation 
of mouse-human heterokaryons Journal of Cell Science 7 (1970) 319-335. 
[3] F. Loor, Lectin-induced lymphocyte agglutination.  An active cellular process? 
Experimental Cell Research 82 (1973) 415-425. 
[4] K. Simons and E. Ikonen, Functional rafts in cell membranes Nature 387 (1997) 569-572. 
[5] K. Ritchie, R. Iino, T. Fujiwara, K. Murase and A. Kusumi, The fence and picket 
structure of the plasma membrane of live cells as revealed by single molecule techniques 







CHAPTER I: Peter W. Winter performed fluorescence correlation spectroscopy shown in Figure 
4 and Figure 5 and photon counting histogram analysis shown in Table 5. 
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Single particle tracking was used to evaluate lateral motions of individual FLAG-
tagged human luteinizing hormone (LH) receptors expressed on Chinese hamster ovary 
(CHO) cells and native LH receptors on both KGN human granulosa-derived tumor cells 
and M17 human neuroblastoma cells before and after exposure to human chorionic 
gonadotropin (hCG).  Compared to LH receptors on untreated cells, LH receptors on cells 
treated with 100 nM hCG exhibit restricted lateral diffusion and are confined in small, 
nanometer-scale, membrane compartments. Like LH receptors labeled with Au-hCG, LH 
receptors labeled with Au-deglycosylated hCG, an hCG antagonist, also exhibit restricted 
lateral diffusion and are confined in nanoscale membrane compartments on KGN cells 
treated with 100 nM hCG. LH receptor point mutants lacking potential palmitoylation sites 
remain in large compartments despite treatment with 100 nM hCG as do LH receptors on 
cells treated with cytochalasin D.  Finally, both polarization homo-transfer fluorescence 
resonance energy transfer imaging and photon counting histogram analysis indicate that 
treatment with hCG induces aggregation of YFP-coupled LH receptors stably expressed on 
CHO cells.  Taken together, our results demonstrate that binding of hCG induces 
aggregation of LH receptors within nanoscale, cell-surface membrane compartments, that 
hCG binding also affects the lateral motions of antagonist binding LH receptors, and that 
receptor surface densities must be considered in evaluating the extent of hormone-
dependent receptor aggregation. 
 
Signal transduction by luteinizing hormone1 (LH) receptor plays an essential role in the 
normal reproductive function of both male and female mammals by promoting ovulation, 
follicle maturation, corpus luteum formation and steroidogenesis.  LH receptor signaling in 




substantial changes in receptor lateral and rotational dynamics (1,2) as well as the association of 
LH receptors with membrane rafts (3). Fluorescence resonance energy transfer (FRET) 
techniques (4) and electron microscopy (5) indicate that functional hormone-receptor complexes 
can also become self-associated into dimers/oligomers following ligand binding.  Previous 
experimental strategies have examined changes in receptor motions on collections of cells or 
large numbers of fluorescently-tagged molecules on single cells.  It is now possible, however, to 
examine the lateral motions of individual LH receptors on living cells using microscope-based 
single particle tracking (SPT) techniques (6). 
 Although the mechanism involved in retention of hCG-occupied LH receptors in small 
membrane compartments is still unclear, exposure to saturating concentrations of hCG results in 
confinement of the majority of LH receptors within small cell-surface compartments.  LH 
receptors remain within these compartments for comparatively long times and appear to diffuse 
pseudo-randomly before being captured within another compartment of similar size (7).  Similar 
behavior has been described and analyzed by Kusumi and coworkers (6) for selected 
phospholipids and for transferrin receptors (8) and by Daumas and coworkers (9) for the μ opioid 
receptor.  Daumas argues that the μ opioid receptor can both diffuse within the bulk membrane 
and exhibit confinement within a microdomain that itself diffuses slowly.  Kusumi and coworkers 
(6) suggest that particles may be confined by proteins forming a barrier that is either continuous 
or discontinuous, leading to receptor diffusion within small membrane regions accompanied by 
intermittent escape from compartments and periods of unrestricted diffusion in the bulk 
membrane.  
 Our previous studies of LH receptor lateral and rotational diffusion suggest that actin 
microfilaments or membrane protein interactions with the cytoskeleton may provide organizing 
structures that restrict the lateral motions of receptors (1,2).  However, the mechanism of 
hormone-initiated LH receptor confinement in small compartments has not previously been 




dynamics of individual LH receptors that were either FLAG-tagged and identified using FLAG-
specific antibodies with the diffusion of native receptors occupied by gold nanoparticle-hCG 
conjugates (Au-hCG) or Au-deglycosylated DG-hCG (Au-DG-hCG).  The latter material is an 
hCG antagonist (10) that binds LH receptors with high affinity and can block hCG binding for 
more than 24 hrs (11).  This allowed us to determine whether LH receptor motions are dependent 
on hCG concentration and limited to hCG-occupied receptors or, alternatively, whether hCG 
binding to a fraction of available receptors has global effects on LH receptor diffusion regardless 
of whether they have been activated by hCG.  We also explored whether point mutations to 
palmitoylation sites on the LH receptor C-terminus, known to eliminate LH receptor translocation 
into membrane rafts (12) affected receptor confinement within small compartments and to what 
extent the actin cytoskeleton is responsible for the restriction of LH receptor lateral motions.  
Because slower lateral diffusion may result from extensive self-association of membrane proteins, 
polarization homo-transfer FRET (homoFRET) and photon counting histogram (PCH) analysis 
were utilized to evaluate increased oligomerization of YFP-coupled human LH receptors (YFP-
LHR) stably expressed on individual, viable, CHO cells in response to increasing concentrations 
of hCG.  Fluorescence correlation spectroscopy (FCS) was used to determine the equilibrium 
dissociation constant (KD) of hCG binding to native LH receptors on KGN cells and to estimate 
the number of native LH receptors on these cells. FCS was also used estimate the number of 
YFP-LHR stably expressed on the CHO cells used in homoFRET and PCH analysis studies.  
Finally, we considered how changes in receptor cell surface density might contribute to the 
apparent aggregation of YFP-LHR stably expressed on CHO cells. 
 
EXPERIMENTAL PROCEDURES 
Materials and cell culture ─ CHO cells were maintained in high glucose Dulbecco’s 
Modification of Eagle’s Medium (DMEM) (Mediatech, Inc., Manassas, VA) supplemented with 




streptomycin/ml (Gemini Bio-Products, Woodland, CA) and 1x MEM non-essential amino acid 
solution (Sigma-Aldrich, Inc., St. Louis, MO).  KGN cells, a human granulosa-like tumor cell 
line developed by Dr. Yoshihiro Nishi and Dr. Toshihiko Yanase at Kyusyu University (13), were 
kindly provided by Dr. James Dias at the Wadsworth Center (New York State Department of 
Health, Albany, NY).  KGN cells were maintained in DMEM/Ham’s F12 medium supplemented 
with 10% FBS, 2 mM L-glutamine and 100 units of penicillin/mL as previously described (13).  
M17 human neuroblastoma cells which express LH receptors (14) were purchased from ATCC 
(Manassas, VA) and maintained in Minimum Eagle’s Medium (MEM)/Ham’s F12 medium 
(Mediatech, Inc., Manassas, VA) supplemented with 10% FBS, 2 mM L-glutamine, 100 units of 
penicillin/mL, 100 μg streptomycin/mL (Gemini Bio-Products, Woodland, CA), 1.5 g/L sodium 
bicarbonate, 1 mM sodium pyruvate and 0.1 mM MEM non-essential amino acid solution 
(Sigma-Aldrich, Inc., St. Louis, MO).  All cells were grown in 5% CO2 at 37ºC in a humidified 
environment.  Geneticin (G418 sulfate) was purchased from Mediatech, Inc. (Manassas, VA).  
Monoclonal anti-FLAG antibody directed against the FLAG epitope tag was purchased from 
Sigma-Aldrich, Inc. (St. Louis, MO).  40 nm gold colloid was obtained from Ted Pella, Inc. 
(Redding, CA).  Highly purified hCG (Fitzgerald Industries, Inc., Concord, MA) was prepared in 
1x PBS.  Dr. George Bousfield, Wichita State University, kindly provided deglycosylated hCG 
used in single particle tracking studies on KGN and M17 cells.  Deglycosylated hCG was 
prepared using modifications of the method described by Edge et al. (15).  Rather than using a 
desalting column as described, deglycosylated protein was incubated in 0.5 M sodium acetate 
buffer, pH 6.0, overnight at 37 C to re-associate dissociated subunits and the heterodimer fraction 
was then isolated using Superdex 75 gel filtration chromatography. To monitor the extent of LH 
receptor signaling in M17 cells, levels of intracellular cAMP were assessed following exposure to 





CHO cell lines expressing FLAG or YFP tags ─ Dr. K.M. Menon from the University of 
Michigan kindly provided us with N-terminal FLAG-tagged LHR subcloned into the pFLAG 
vector (FLAG-LHR) (Sigma-Aldrich, Inc., St. Louis, MO).  A stable cell line expressing FLAG-
tagged palmitoylation-deficient LH receptors was prepared as previously described (12).  For 
homoFRET, FCS and PCH experiments, we used a stable CHO cell line expressing human YFP-
LHR at the C-terminus as previously described (16).   
Single particle tracking of individual LH receptors on live cells ─ Lateral dynamics and 
the size of compartments accessed by individual FLAG-LHR on CHO cells or native LH 
receptors on KGN and M17 cells were evaluated using single particle tracking methods as 
described by Kusumi and coworkers (17).  To identify FLAG-LHR, 40 nm nanogold particles 
were conjugated with a mixture of anti-FLAG monoclonal antibody and BSA at the lowest 
possible total protein concentration, typically 40 µg/mL, needed to stabilize the gold solution.   
To identify individual native LH receptors expressed on KGN or M17 cells, 40 nm gold particles 
were coupled to Au-hCG or Au-DG-hCG using the same protocol. For labeling cells, the ratio of 
antibody or hormone to BSA, typically 1:100 by weight, was selected to give 10 to 20 particles 
bound per cell.  The binding of anti-FLAG antibody or hormone was specific: when cells were 
preincubated with a 10-fold excess of anti-FLAG antibody or Au-tagged hormone, no gold 
particles were detected on cells.   Cells were labeled with Au-coupled probes for 1 hour at 4°C.  
After receptor labeling, cells were treated with 0.1 nM, 1 nM or 100 nM hCG for 1 hour at 37°C.  
Because the off rates for hCG and DG-hCG are on the order of 24-48 hours  (11,18),  it is 
unlikely that Au-tagged hormones were displaced from LH receptors by introduction of hCG on 
the timescale of these experiments. In some experiments, cells grown on coverslips placed in 60 
mm2 petri dishes were pre-treated with 40 μg/mL cytochalasin D for 1 hour prior to labeling with 
gold-conjugated anti-FLAG antibody. 
Individual gold nanoparticles were imaged by differential interference contrast using a 




acquired using a Dage IFG-300 camera and were recorded for two minutes (3600 frames) at 
approximately 30 nm/pixel under the control of Metamorph software (Molecular Devices).  
Trajectories of individual gold particles were measured over time and then segmented into 
compartments by calculation of statistical variance in particle position (6,9,19).  The variance of a 
particle's position was calculated within windows of varying duration which were translated 
along the particle trajectory, producing a variance plot that exhibited peaks indicating inter-
compartment boundaries.  These results were analyzed using custom analysis programs to yield 
the compartment size and residence time for each particle.  Effective macroscopic diffusion 
coefficients (D) were calculated as the square of the compartment diagonal divided by four times 
the residence time in the compartment as previously described (19).  Data are presented either as 
the mean ± S.E.M. or mean ± S.D. as indicated in the figure legends.  Significance was assessed 
using Student’s t-test and p values are indicated (p < 0.05).  
Polarization homo-transfer FRET measurements ─ We investigated aggregation of 
human LH receptors in response to 0.1 nM, 1 nM and 100 nM hCG using polarization homo-
transfer FRET or energy migration FRET.  Homo-transfer FRET assesses energy transfer 
between identical fluorescent donor and acceptor molecules by measuring fluorescence 
anisotropy as probe molecules are photobleached (20).  Increasing anisotropy as probe molecules 
are progressively photobleached is indicative of FRET.  CHO cells stably expressing YFP-LHR 
were plated overnight in Willco 35 cm2 #1.5 glass bottom petri dishes (Warner Instruments, 
Hamden, CT).  FRET between YFP molecules on single cells were analyzed using an Olympus 
FV 300 confocal microscope with a polarizing beam splitter placed in front of the detection 
PMTs, allowing two orthogonally-polarized fluorescence images to be recorded simultaneously.  
YFP was excited with the 488 nm line of an argon laser and appropriate barrier and dichroic 
filters were selected for YFP emission.  Individual cells with ring-like fluorescence from YFP at 
their plasma membrane were imaged.  A sequence of cell images, typically about 20, was 




intensity remained.  Each anisotropy measurement was accompanied by acquisition of g-factor 
and background images.  Imaging analysis was performed with custom analysis programs.  Total 
intensity (s) and fluorescence anisotropy (r) were calculated as s=I║ + 2I┴ and r=( I║ - I┴)/s, where 
I║ and I┴ are fluorescence emission polarized parallel and perpendicular, respectively, to the 
polarization of linearly polarized excitation light (21,22). 
Fluorescence correlation spectroscopy and photon counting histogram analysis ─ PCH 
analysis was used to evaluate oligomerization of YFP-LHR stably expressed on CHO cells in 
response to increasing concentrations of hormone.  The related technique FCS was used to 
determine the KD of hCG binding to native LH receptors on KGN cells and obtain estimates of 
the number of LH receptors on KGN cells and on CHO cells expressing YFP-LHR.  KGN cells 
were seeded onto sterile dishes, grown to 50% confluence, washed, and treated with 0.01 – 500 
nM hCG for 45 min.  Cells were then washed and sequentially treated with anti-hCG rabbit IgG 
(Upstate) for 30-40 min, 600 nM anti-rabbit-biotin IgG (Sigma) for 30 min, and 600 nM FITC-
avidin for 20 min before observation.  CHO cells stably expressing YFP-LHR were grown to 
50% confluence on sterile dishes and examined directly.  Both FCS and PCH experiments were 
performed on a modified Nikon TE1000 inverted microscope equipped with a 100x, 1.25 NA, 
oil-immersion objective, an Omnichrome Melles-Griot multi-line air-cooled argon ion laser 
operating at 514.5 nm, two 570/32 nm bandpass filters, two PerkinElmer single photon counting 
modules (SPCM-AQR-14), an ALV-6010 digital hardware correlator and a Becker and Hickl 
GmbH PMS-400 multichannel photon counter as previously described (23).  The 1/e2 radius of 
the excitation beam at the sample was experimentally determined to be 241 nm using aqueous 
rhodamine 6G.  In live cell studies, the laser excitation beam was vertically positioned on the 
apical cell membrane by adjusting the objective z-position to maximize detector count rates and 
minimize diffusional correlation times (τD) as described by Ries and Schwille (24).  All FCS and 
PCH experiments were conducted at room temperature. In both FCS and PCH experiments 




irreversible photobleaching of immobile particles (25). FCS data were then collected for two 
consecutive 10 sec intervals, while PCH data were collected for 30 sec.  During acquisition of 
FCS and PCH data the average fluorescence from the sample was relatively uniform as indicated 
by the avalanche photodiode signal readouts. Analysis of FCS data, including determination of τD 
and the normalized initial g(τ) were accomplished according to established procedures using Igor 
Pro 5.05A (24,26-28). Using FCS, the number of receptors per μm2 was determined from the 
effective number of correlating particles detected in the illuminated area (Neff) at saturating 
concentrations of fluorophore conjugated receptor-specific probe and the radius of the laser 
interrogation area. The KD for hCG was determined by fitting FCS data to a hyperbolic function 
describing a single-site binding model. For PCH, detected photons were accumulated into 
successive 1 μs counting channels and rebinned into 9 μs channels to improve signal-to-noise. 
Rebinned photon counts were then simultaneously subjected to autocorrelation, pseudo-
crosscorrelation and PCH. Weighted least-squares fitting was used to obtain estimates of Neff, the 
average molecular brightness (ε) of detected particles and the out-of-focus emission ratio (F) as 
previously described (29-31).  
 
RESULTS 
Reduced lateral diffusion and increased compartmentalization of LH receptors follows 
treatment with hCG ─ Single particle tracking methods were used to examine the lateral diffusion 
of individual LH receptors and receptor compartmentalization in response to binding of hCG 
(Figure 1.1).  Treating CHO cells expressing FLAG-LHR with 0.1 nM hCG did not have a 
statistically significant effect on either receptor diffusion (lower panel) or average size of 
compartments containing LH receptors (upper panel).  However 1 nM hCG and 100 nM hCG 
significantly increased the number of receptors appearing in compartments of less than 100 nm in 




FLAG-LH receptors on cells treated with 100 nM hCG, also exhibited significantly slower lateral 
diffusion (Figure 1.1, lower panel).   
To examine the lateral dynamics of native LH receptors on viable KGN granulosa-like 
tumor cells and M17 human neuroblastoma cells, 10-20 receptors per cell were tagged with Au-
hCG. When KGN cells were exposed to 1 nM and 100 nM unlabeled hCG, Au-tagged LH 
receptors became confined in small membrane compartments of less than 100 nm diameter 
(Figure 1, upper panel). For cells treated with 0.1 nM hCG, 16% of hCG-occupied LH receptors 
on KGN cells were confined in these small compartments and this number increased to 48% 
when cells were treated with 100 nM hCG. The diffusion rate of individual LH receptors was also 
reduced from 0.7±0.2 x10-11cm2sec-1 to 0.3±0.1 x10-11cm2sec-1 after 100 nM hCG treatment 
(Table 1.1).  We observed similar dose-dependent effects of hCG on the diameter of 
compartments accessed by hCG-occupied LH receptors on M17 neuroblastoma cells.  With 
increasing concentrations of hCG, more Au-hCG occupied LH receptors were confined in small 
membrane compartments.  Au-hCG occupied LH receptors on cells treated with 100 nM were 
located in smaller compartments with an average diameter of 131±18 nm.  In M17 cells the 
average rate of diffusion was reduced from 0.9±0.3 x10-11cm2sec-1 to 0.4±0.1 x10-11cm2sec-1 after 
treatment with 100 nM hCG (Table 1.2).   
Activation of LH receptors also resulted in increased levels of intracellular cAMP.  There 
was a 1.6±0.2-fold and a 2.5±0.9-fold increase in cAMP response over basal levels, respectively, 
in response to treatment with 100 nM hCG and 20 nM forskolin.   
Non-functional receptor complexes exhibit reduced lateral diffusion and increased 
compartmentalization in response to hCG ─  Differences in the effects of hCG on the lateral 
motions of FLAG-LHR and native receptors on KGN and M17 cells were anticipated, 
particularly at lower hormone concentrations.  When cells are treated with lower concentrations 
of hCG, FLAG-tagged receptors are not necessarily occupied by hCG. In contrast, only Au-hCG-




To determine whether hCG binding to LH receptors produced global effects on LH receptor 
motions or, alternatively, affected only hCG-occupied receptors, native LH receptors on KGN 
cells were labeled with 10-20 Au-DG-hCG molecules as probes for non-signaling receptors.  
Compared to Au-hCG occupied LH receptors, Au-DG-hCG occupied LH receptors exhibited 
relatively faster lateral diffusion within somewhat larger 217±27 nm diameter regions. When 
KGN cells were treated with 100 nM hCG, Au-DG-hCG occupied receptors also exhibited 
significantly slower lateral diffusion and became confined in smaller compartments, although 
neither receptor lateral diffusion nor average compartment size were affected by hormone 
treatment to the same extent as seen for Au-hCG occupied receptors.  The results from these 
experiments are summarized in Table 1.1. 
 Mutation of palmitoylation sites on LH receptors or disruption of actin microfilaments 
prevents hormone-mediated receptor confinement  ─  We examined LH receptor lateral 
motions and confinement in small compartments on cells expressing LH receptors in which 
cysteine was mutated to serine at positions 621 and 622 (LHR-C621, 622S), previously described 
as palmitoylation sites for the LH receptor (32,33).  The average values for the compartment 
diameters accessed by either untreated or hCG-treated LHR-C621, 622S are approximately 200 
nm (Table 1.3).  In addition, FLAG-LHR on CHO cells treated with 40 μg/mL cytochalasin D, an 
actin-filament disrupter (34-37), exhibit fast lateral diffusion within large compartments both 
before and after exposure to 100 nM hCG. After treatment with cytochalasin D, hCG had no 
effect on the average diffusion coefficient or the average compartment diameter accessed by 
FLAG-LHR.  This may be a result of the disruption of cell-surface compartments defined by 
cytoskeletally-anchored proteins (38).  Individual LHR-C621, 622S were also generally not 
confined in small compartments although their diffusion coefficients were slower than those of 
either untreated wild type LH receptors or LH receptors on cells treated with cytochalasin D 




Human LH receptors self-associate in response to increasing concentrations of hCG ─ 
Aggregation of LH receptors in response to hormone treatment was assessed using CHO cells 
stably expressing YPF-LH receptors and both homo-transfer FRET confocal imaging and PCH 
analysis (39). In homo-FRET studies, fluorescence emission anisotropy was measured as YFP 
molecules were irreversibly photobleached.  Progressive loss of YFP molecules via irreversible 
photobleaching reduces the likelihood that two YFP molecules are in close proximity to one 
another and available for resonance energy transfer.  Thus the anisotropy of fluorescence 
emission will increase with increasing photobleaching of the YFP fluorophore.  The average 
percent increase in anisotropy for untreated CHO cells expressing human YFP-LHR  was 11%, 
26% for cells treated with 0.1 nM hCG, 36% for cells treated with 1 nM hCG and 54% for cells 
treated with 100 nM hCG (Figure 1.3).  FRET efficiencies (E), calculated as described by Rao 
and Major (40), increased from about 9% for untreated cells to over 30% in response to 
increasing concentrations of hCG (Table 1.4). 
Similarly, PCH analysis suggests that YFP-LHR undergo aggregation after exposure to 
hCG. The average photon counts detected per molecule per sampling time, often referred to as ε 
(31,41) for YFP-LHR on live CHO cells was 0.07 ± 0.01 before treatment with hCG.  After 
treatment with increasing concentrations of hCG, the ε of detected YFP-LHR rose significantly 
to 0.13-0.14 (Table 1.5) suggesting increased aggregation of LH receptors in response to 
binding of ligand. 
Finally, FCS was used to determine the number of YFP-LHR per μm2 on the surface of 
the stably transfected CHO cells and to compare that to native LH receptor density on KGN 
cells.  Figure 1.4 shows the distribution of YFP-LHR densities on individual CHO cells and 
indicates that the majority of these cells have LH receptor densities ranging from 10 receptors 
μm-2 to 100 receptors μm-2.  This was similar to the number of YFP-LHR observed during PCH 
analysis (Table 1.5).  Also, on average, the density of LH receptors on KGN cells (Figure 1.5), 




CHO cells.  These experiments also indicate that native LH receptors on KGN cells bind hCG 
with KD of approximately 210 pM which is similar to previously determined values obtained 
using alternative methods (42).  Using known estimates of CHO cell surface area (43), we 
calculate that each transfected CHO cell expresses approximately 33,000 total YFP-LHR.  
 
DISCUSSION 
 We have previously shown that binding of saturating concentrations of hCG to rat LH-wt 
receptors results in redistribution of essentially all LH receptors from the bulk membrane into 
cholesterol-enriched membrane rafts (7) and that LH or hCG treatment cause a marked reduction 
in the fraction of mobile receptors (44).  In contrast to methods used in these previous studies, 
single particle tracking techniques probe the lateral motions of individual LH receptors rather 
than a large population of receptors and so permit analysis of specific sub-populations of 
receptors exhibiting unique diffusive properties.  Here we have shown that, when cells were 
treated with 100 nM hCG, a concentration sufficient to saturate available LH receptors, the 
average diffusion coefficient for individual receptors was approximately 10-12cm2sec-1. This 
agrees with previous measurements of lateral diffusion for LH receptors on ovine luteal cells (45) 
and cell lines stably expressing LH receptors covalently coupled to visible fluorescent proteins 
(46) where most, if not all, LH receptors binding either saturating concentrations of LH or hCG 
were laterally immobile on the timescale of photobleaching recovery experiments.  These 
laterally immobile receptors had diffusion coefficients estimated to be less than 10-12cm2sec-1 (47), 
a practical detection limit for fluorescence photobleaching recovery measurements. 
 It appears that the extent of receptor occupancy by hormone is related to LH receptor 
retention in small compartments where individual particles exhibit slower diffusion. These should 
be considered distinct from membrane rafts (48) which are small microdomains within the 
membrane that may be transiently organized as proteins and small numbers of associated lipids or 




in small membrane compartments when treated with cytochalasin D, a disruptor of the actin-
based cytoskeleton (34-37), suggesting that the compartments evaluated with single particle 
tracking methods are bounded by protein fences or cytoskeletally-anchored protein networks that 
limit lateral diffusion of transmembrane proteins (6).  It is also possible that the restriction of LH 
receptor lateral motions involves both lipid rafts and protein delineated networks nested in a 
hierarchical fashion as has recently been proposed (50). 
 Interestingly, individual LHR-C621,622S were generally not confined in small 
compartments. Nevertheless, their diffusion coefficients were slower than those of either 
untreated FLAG-LH receptors or FLAG-LH receptors on cells treated with cytochalasin D. 
Although palmitoylation-deficient mutant LH receptors are not found in rafts (12), they retain 
their ability to signal via cAMP (32,33) as do dopamine D1 (51) and serotonin 4a (52) receptors 
with similar mutations.  These results suggest that either prolonged LH receptor retention in small 
membrane compartments is not required for LH receptor-mediated signal transduction or, 
alternatively, that interactions of mutant receptors with the molecular contents of small 
compartments are more short-lived than for wild type receptors but still sufficient to initiate 
downstream signaling events.   
  Single particle tracking studies of endogenous LH receptors demonstrated that native 
hCG-occupied LH receptors on KGN human granulosa or M17 human neuroblastoma cells 
exhibited a dose-dependent increase in receptor compartmentalization in response to increasing 
concentrations of hCG which, in M17 cells, corresponded to increases in cAMP.  The relationship 
between receptor compartmentalization and cAMP signals in these neuronal tissue may be 
important in aging where elevated LH levels are associated with decreased cognition in animal 
models (53).  It may also suggest a role for deglycosylated hCG or other hCG antagonists in 
reducing compartmentalization of LH receptors, particularly if compartmentalization of LH 





 However, the question of whether binding of hCG has global effects on the motions and 
compartmentalization of both hormone-occupied and unoccupied LH receptors remains 
unresolved.  In KGN cells, DG-hCG-tagged LH receptors were confined in smaller compartments 
when cells were exposed to saturating concentrations of hCG (100 nM) suggesting that some non-
functional hormone-receptor complexes may redistribute into small membrane compartments 
together with hCG-occupied receptors. It is important to note that high concentrations of DG-
hCG alone do not alter the molecular motions of LH receptors or lead to accumulation of LH 
receptors into small membrane microdomains.  The rotational diffusion coefficients for LH 
receptors remain fast when receptors are occupied by DG-hCG (54) and there is no evidence of 
raft localization or confinement of DG-hCG occupied LH receptors in small nanoscale membrane 
microdomains using SPT (7). Similarly, non-functional hormone receptor complexes formed by 
binding of hCG to non-signaling LH receptor mutants exhibit faster rotational diffusion (54) than 
do functional hormone-occuped LH receptors (55), no increase in FRET in response to ligand (4) 
and are not confined in either raft domains or membrane microdomains examined using SPT (7).  
These results suggest that the slower lateral dynamics observed for Au-DG-hCG when cells are 
treated with hCG may result from a bystander effect on Au-DG-tagged receptors that may include 
direct interactions between hCG-occupied LH receptors and the Au-DG-hCG occupied receptors 
similar to LH receptor trans-activation described by Ji and coworkers (56).   
 These studies do no resolve the extent to which LH receptors may exist as pre-
aggregated dimers or low molecular weight oligomers prior to binding hormone. Analysis of such 
structures on living cells would require single molecule methods for evaluating, for example, 
single molecule measurements of FRET analogous to SPT measurements of lateral diffusion.  
Nevertheless, it is clear that there are hCG-dependent increases in the extent of LH receptor 
aggregation regardless of whether the receptor exists initially as a monomer, dimer or larger 
structure.  Using homo-transfer FRET techniques to evaluate interactions between stably 




association than untreated LH receptors and that the extent of receptor interactions is dependent 
on hormone concentrations.   Similar results were also observed in PCH analysis of changes in ε 
of YFP-LHR aggregation on CHO cells after hormone treatment.     
 The hCG-dependent increase in ε also argues against a conformational change in LH 
receptors leading to increased FRET. There have, in addition, been previous observations of 
FRET made using fluorescein isothiocyanate (FITC)-hCG and tetramethylrhodamine 
isothiocyanate (TrITC)-hCG as a donor/acceptor pair under conditions where the formation of 
large molecular weight complexes containing LH receptors was assessed.  Using membrane 
preparations from  porcine granulosa cells, the GTP-dependent progression from “active” LH 
receptors to  “desensitized” LH receptors was accompanied by an increase in FRET efficiency 
from values less than 1% to over 10%.  Increased FRET efficiency was accompanied by slower 
receptor rotational dynamics indicative of receptors within large molecular weight structures (57).  
Because both active and desensitized LH receptors in these studies were occupied by hCG, the 
absence of FRET between “active” receptors also suggests that FRET does not result from an 
agonist-stabilized receptor conformation.   
 Importantly, the surface density of stably-transfected LH receptors on these CHO cells 
was comparable to that of native LH receptors expressed by KGN cells.  This suggests that CHO 
cells were not expressing unrealistically high levels of YFP-LHR.  Nonetheless, evidence for 
some energy transfer between LH receptors expressed at physiologically-relevant numbers raises 
questions about the role of receptor density in receptor-receptor interactions.  Figure 6 shows the 
extent E of spontaneous FRET arising from an increase in molecular density.  As shown in Figure 
6, the probability of energy transfer for receptors expressed at a uniform surface density of 20 
receptors μm-2 and a Förster critical distance (r0) of 4.5 nm is less than 1%.  The likelihood of 
receptor interactions, simply as a function of receptor density, increases with increased receptor 




efficiency of transfer for given value of r0 is shown to be 1-exp[-(2π2/3√3)σr02] (see Supplemental 
Material).   
 From estimates of spontaneous FRET shown in Figure 6, it seems likely those CHO cells 
stably expressing LHR-GFP with receptor densities that are 2-3 fold greater than the average 
number of receptors/cell may contribute the FRET efficiencies observed for untreated cells in this 
study.  Substantial FRET will be observed even for homogeneously-distributed molecules if 
expressed at higher, but commonly encountered, levels.  For instance, ErbB1 expressed at levels 
of 50,000-200,000 receptors per cell is monomeric.  At receptor numbers greater than 500,000, 
approximately 30% of these receptors are in pre-formed dimers (58).  Moreover, lateral 
compartmentalization can only increase the likelihood of apparent FRET.  If an acceptor 
molecule with r0 of 5 nm in a hetero-FRET pair or a donor molecule in homo-FRET is expressed 
at an average density of 500 µm-2 but is confined in lateral compartments occupying 10% of the 
cell- surface, then an apparent FRET efficiency of 50% would arise solely from molecular 
crowding. 
Nonetheless, these FRET results agree with previous studies showing increased 
interactions between LH receptors following hCG treatment.  These studies have measured FRET 
between FITC- and TrITC-derivatized hormones or between LH receptors tagged with either 
visible fluorescent protein (VFP) donor or acceptor. VFP-tagged wild type rat LH receptors 
occupied by either LH or hCG had FRET efficiencies of 13-17%.  More importantly, most LH 
receptors interacted only after binding ligand (44) and only functional ligand-receptor complexes 
or constitutively active LH receptors showed evidence of such interactions (16).  In the absence 
of ligand, values for energy transfer efficiency between stably expressed, VFP-tagged hLHR-wt 
receptors on individual cells were typically less than 1% while constitutively active receptors also 
appeared to be constitutively self-associated with values for energy transfer efficiency greater 
than 10% (16). These various FRET results agree with electron microscopy studies of rat 




showed evidence of receptor-receptor interactions and with immunofluorescence studies of the 
LH receptor on rat granulosa cells where large, punctate structures formed on the cell membrane 
following treatment with hCG (60). 
 Methodological differences may account, however, for a report by Tao et al. (61) 
suggesting that LH receptors may self-associate in the endoplasmic reticulum and remain 
constitutively associated when expressed at the plasma membrane.  These studies were performed 
using immunoprecipitation of receptors following cell solubilization, an approach that has 
significant drawbacks (62), as well as by bioluminescence resonance energy transfer, BRET1 and 
BRET2, techniques.  Similarly, Urizar et al. (63) have suggested that LH receptors are 
constitutively self-associated as has Guan et al. (64).  As with co-immunoprecipitation studies of 
the LH receptor, BRET studies examine receptor interactions on large numbers of cells that are 
transiently transfected and can, under conditions where expression levels are high, lead to random 
receptor interactions (65) and non-physiological receptor aggregation simply due to molecular 
crowding (62). 
 In addition, the number of molecules expressed in individual cells following transient 
transfection may exhibit larger cell to cell variation than, for example, CHO cells stably 
expressing YFP-LHR.  As an example, flow cytometric analysis of cells transfected with a 
membrane-targeted form of GFP show that about 17% of cells express detectable levels of GFP 
(66) and, when cells do express GFP, the amount per cell can vary over 100-fold.  In a BRET 
experiment, signal comes from cells that express the donor/acceptor pair and, amongst this group 
of cells, a disproportionally high signal will arise from cells that highly express the BRET pair.  
Although reducing the amount of DNA used to transfect cells reduces protein expression and the 
average level of fluorescence within a cell population, this would not alter cell-to-cell differences 
in the number of expressed molecules or the disproportionate contribution to BRET signal by 
cells that over-express the proteins in question.   The use of BRET pairs may also magnify this 




for a resonance energy transfer pair used in biological studies (67), and, as shown in Figure 1.6, 
the effect of protein density on FRET efficiency is greater for energy transfer pairs with larger r0. 
 Finally, ligand-induced receptor conformational changes may increase the likelihood of 
receptor interactions with the membrane cytoskeleton.  Given the dynamic nature of the 
cytoskeleton, such molecular complexes can be expected to generate apparent 
compartmentalization of receptor motions over a range of times and distances. Presumably, hCG-
induced formation of larger complexes of LH receptors, signaling molecules or other cytoplasmic 
proteins enhances interaction with elements of the cytoskeleton and reduces the apparent size of 
the compartments confining the receptors.  Nonetheless, understanding the relationship between 
receptor-mediated signaling and LH receptor palmitoylation, aggregation  and confinement in 
membrane rafts or larger membrane compartments will require more detailed examination of 
confined receptors and local signaling events, a process that will likely involve microscopic 
resolution of membrane microdomains and single molecule detection methods for identifying 
locally high concentrations of second messengers such as cAMP. 
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Figure 1: Compartment sizes (upper panel) and diffusion coefficients (lower panel) for CHO cells 
expressing FLAG-LHR and for native LH receptors on KGN and M17 cells before and after 
treatment with 0.1 nM to 100 nM hCG.  Data shown are the mean ± S.E.M. where data groups 
marked a, b, c, d, e and f differ significantly (p<0.05). 
 
Figure 2: Distribution of compartment sizes accessed by FLAG-LH receptors stably expressed on 
CHO cells before (●) and after treatment with 0.1 nM hCG (○), 1.0 nM hCG (▼) or 100 nM hCG 
(Î).   
 
Figure 3: Initial and final anisotropy measured before and after photobleaching of YPF coupled to 
LHR.  Data shown are the mean and S.E.M. of at least 20 measurements on individual cells 
where data groups marked a,b,c,d,e and f differ significantly (p<0.01).  The origin of the smaller 
S.E.M. for the difference (rfinal-rinitial) relative to separate values of rinitial and rfinal is explained in 
the text. 
 
Figure 4: Distribution of stably expressed YFP-LHR surface-densities for 58 individual CHO 
cells as determined by fluorescence correlation spectroscopy.  
 
Figure 5: Number of hCG molecules bound to LH receptors on KGN cells within the focused 
laser spot as determined by fluorescence correlation spectroscopy.  KGN cells were treated with 
hCG and sequentially labeled with rabbit anti-hCG IgG, biotinylated anti-rabbit IgG and FITC-
avidin as described in Materials and Methods.  Each point (●) shown is the mean ± S.D. of 
measurements from at least 14 individual cells.  
 
Figure 6:  Degree of spontaneous homoFRET arising from various molecular surface densities.  









Au probe        Treatment    Compartments(b)               D0-1(c)               D = Lr2/4t(d)                 Time(e)                    Compartment(f)   
  [hCG]         per trajectory           (10-11cm2sec-1)     (10-11cm2sec-1)                 (sec)                            Size (nm) 
____________________________________________________________________________________________________________ 
 
Au-hCG  None              5 ± 2                   2.8 ± 0.3        0.7 ± 0.2               24 ± 21                     186 ± 211 
 
Au-hCG  0.1  5 ± 2                  2.2 ± 0.2        0.5 ± 0.1                 24 ± 20  156 ± 17 
 
Au-hCG  1  6 ± 2                  2.4 ± 0.2        0.6 ± 0.2          21 ± 17  148 ± 162   
 
Au-hCG  100  6 ± 2                   2.0 ± 0.2        0.3 ± 0.1               20 ± 13  108 ± 112 
 28 Au-DG-hCG None  4 ± 2                  2.0 ± 0.2        1.6 ± 0.9   27 ± 26  217 ± 271 
 
Au-DG-hCG 100  5 ± 1                  2.1 ± 0.2       0.5 ± 0.2         25 ± 18  145 ± 202 
____________________________________________________________________________________________________________ 
(a) Each data point shown is the mean ± S.E.M. from measurements on 10-15 individual cells. 
(b) The average number of compartments accessed by an individual LH receptor during a 2 min, 3600 frame image sequence. 
(c) D0-1: Diffusion coefficient within compartment calculated from the first two points of MSD vs. time plot as described by Daumas et al. (9).   
(d) D represents the diffusion coefficient within a compartment as calculated from compartment size (Lr) and particle residence time (t) as D = 
Lr2/4t as described by Saxton (68). 
(e) Average particle residence time within a compartment. 
(f) The average size of an individual compartment was calculated as described by Daumas et al. (9) and Murase et al. (6).  Values with subscript 2 





Table 1.2:   Effects of hCG treatment on single particle tracking of individual native LH receptors on M17 human neuroblastoma cells using Au-
hCG or Au-DG-hCG probes.(a)  
 ____________________________________________________________________________________________________________ 
 
Au probe        Treatment   Compartments(b)               D0-1(c)               D = Lr2/4t(d)                 Time(e)                    Compartment(f)   
  [hCG]        per trajectory           (10-11cm2sec-1)     (10-11cm2sec-1)                 (sec)                            Size (nm)   
____________________________________________________________________________________________________________ 
 
Au-hCG              None             5 ± 1                 2.1 ± 0.2       0.9 ± 0.3              25 ± 18                       219 ± 221 
 
Au-hCG             0.1               4 ± 1                 2.1 ± 0.2       0.8 ± 0.3                 28 ± 20                           195 ± 261 
 
Au-hCG            1            4 ± 2                 2.3 ± 0.3       0.4 ± 0.1  27 ± 21                      143 ± 172   
 
Au-hCG           100               5 ± 2                  1.9 ± 0.2       0.4 ± 0.1    22 ± 16                      131 ± 182 
 
____________________________________________________________________________________________________________ 
(a) Each data point shown is the mean ± S.E.M. from measurements on 10-15 individual cells. 29 (b) The average number of compartments accessed by an individual LH receptor during a 2 min, 3600 frame image sequence. 
(c) D0-1: Diffusion coefficient within compartment calculated from the first two points of MSD vs. time plot as described by Daumas et al. (9).   
(d) D represents the diffusion coefficient within a compartment as calculated from compartment size (Lr) and particle residence time (t) as D = 
Lr2/4t as described by Saxton (68). 
(e) Average particle residence time within a compartment. 
(f) The average size of an individual compartment was calculated as described by Daumas et al. (9) and Murase et al. (6).  Values with subscript 2 














Table 1.3:  Effects of cytochalasin D treatment on single particle tracking of individual human FLAG-tagged LHR-C621, 622S and FLAG-LHR 
on CHO cells using an Au-anti-FLAG probe.  
____________________________________________________________________________________________________________ 
 
Cell Line               Treatments         Compartments(a)           D0-1(b)                D = Lr2/4t(c)            Time(d)              Compartment(e)   
          [hCG]                 per trajectory       (10-11cm2sec-1)     (10-11cm2sec-1)            (sec)                       Size (nm)                   
____________________________________________________________________________________________________________ 
 
CHO FLAG-LHR        None                       2 ± 1                  3.6 ± 0.9    2.8 ± 0.51   25 ± 18      221 ± 801 
   Cytochalasin D 
 
CHO FLAG-LHR   100 nM hCG                 2 ± 1                 2.8 ± 0.4    2.2 ± 0.41               29 ± 14                  204 ± 661   
              Cytochalasin D    
              
CHO FLAG-LHR         None                       3 ± 1                  1.1 ± 0.1    0.4 ± 0.22   29 ± 12      204± 741 
621,622S      
 
CHO FLAG-LHR          100 nM hCG                 3 ± 1                 1.0 ± 0.2              0.1 ± 0.12                32 ± 1                    195± 471 
621,622S       
____________________________________________________________________________________________________________ 
(a) Each data point shown is the mean ± S.E.M. from measurements on 10-20 individual cells. 
(b) The average number of compartments accessed by an individual LH receptor during a 2 min, 3600 frame image sequence. 
(c) D0-1: Diffusion coefficient within compartment calculated from the first two points of MSD vs. time plot as described by Daumas et al. (9).   
(d) D represents the diffusion coefficient within a compartment as calculated from compartment size (Lr) and particle residence time (t) as D = 
Lr2/4t as described by Saxton (68). 
(e) Average particle residence time within a compartment. 
(f) The average size of an individual compartment was calculated as described by Daumas et al. (9) and Murase et al. (6).  Values with subscript 2 




Table 1.4:  Effects of hCG treatment on efficiency of homoFRET between YFP-LHR  
on CHO cells.(a)  
__________________________________________________________________ 
                  
Treatment     rinitial      rfinal   E (%)(b) 




None   0.18 ± 0.02  0.21 ± 0.03  10%  
 
0.1 nM   0.15 ± 0.01  0.19 ± 0.04  20% 
 
1.0 nM   0.17 ± 0.05  0.23 ± 0.05  26% 
 
100 nM   0.17 ± 0.04  0.26 ± 0.06  34% 
 
__________________________________________________________________ 
(a) Data points shown are the mean ± S.D. 
(b) FRET efficiencies (E) were estimated from average initial and final anisotropy 




































Table 1.5: Effects of hCG treatment on PCH analysis of  
YFP-LHR on CHO cells. 
_____________________________________________ 
 
hCG (nM)  Neff(a)  ε (kHz) (b)   
_____________________________________________ 
 
None   12.5±2.6 0.07±0.01 
 
1   13.6±3.3 0.10±0.03 
 
10   13.4±5.6 0.13±0.03(c)   
 
100   15.2±4.2 0.13±0.02(c)   
 
1000   15.3±3.4 0.14±0.04(c)   
__________________________________________ 
(a) Each data point shown is the mean ± SEM of  
measurements on at least 6 individual cells. 
(b)  Estimates of ε were obtained using a detector bin  
time of 9 μs and F values from 0.5-0.7. Data points  
shown are the mean ± SD. 
(c)  Values were statistically different from cells not  
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We used fluorescence correlation spectroscopy to examine the binding of insulin, insulin-
like growth factor type-1 (IGF1) and anti-receptor antibodies to insulin receptors (IR) and insulin-
like growth factor one receptors (IGF1R) on individual 2H3 rat basophilic leukemia cells.  
Experiments revealed two distinct classes of insulin binding sites, 15,000 high-affinity and 
39,000 low-affinity sites with KD of 0.11 nM and 75 nM, respectively. IGF1 competes with 
insulin for 21,000 low-affinity sites with KD of 0.14 nM and with high-affinity sites with  KD of 
10 nM.  Dissociation rate constants of insulin and IGF1 were determined to be 0.015 min-1 and 
0.013 min-1, respectively, allowing estimation of ligand association rates.   Combined, our results 
suggest that, in addition to IR and IGF1R homodimers, substantial numbers of hybrid IR-IGF1R 
heterodimers are present on the surface of these cells and that significant fractions of insulin and 
IGF1 binding to these cells involves non-cognate receptors and IR-IGF1R hybrids. 
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• FCS permits examination of dynamic interactions between biologically relevant 
molecules on individual live cells.  
• 2H3-RBL cells express substantial levels of IR and IGF1R homodimers, as well as, 
hybrid IR-IGF1R heterodimers. 
• Insulin and IGF1 compete with differing affinities for available binding sites on these 
cells. 






















Traditional approaches for the examination of cell surface receptor density and ligand 
binding often rely on radio-labeled ligands or fluorescence intensity measurements on bulk 
solutions [1, 2].  Unfortunately, these methods suffer from inherent drawbacks such as the need 
for large numbers of cells and, in cases where receptor numbers are very low, can fail to detect 
specific binding.  In contrast, fluorescence correlation spectroscopy (FCS) is a versatile technique 
capable of examining interactions between small numbers of biological molecules under 
physiological conditions [3, 4].  Initially introduced in the 1970’s [5-7], FCS has since become a 
versatile tool for the characterization of dynamic biological processes [8, 9].  FCS extracts 
information from the fluctuations in fluorescence intensity that occur as molecules move into and 
out of a femtoliter-size observation volume [10].  This optically-defined interrogation volume, 
coupled with high photon sensitivity, permits the examination of as few as 1-2 fluorescing 
molecules at specific points of interest on the cell membrane or within the cell interior [11, 12], 
allowing real-time measurement of interactions between receptors and ligands [13].  Variations of 
FCS have recently been used in live cells to examine epidermal growth factor receptor clustering 
[14], the kinetics of RhoGTPase-Cdc42 effector complex dissociation [15] and interactions 
between Src peptides and DNA [16].  Ease of use with live cells, the ability to monitor molecular 
dynamics across a broad timescale and the relatively short time needed for data acquisition make 
FCS particularly well suited for the examination of molecular interactions at the single molecule 
level. 
 We report here the use of FCS to determine the surface densities and ligand binding 
thermodynamics and kinetics of insulin receptors (IR) and insulin-like growth factor 1 receptors 
(IGF1R) on live 2H3 rat basophilic leukemia (2H3-RBL) cells.  IR and IGF1R are two 
structurally similar tyrosine kinase receptors with differential effects on cell growth and energy 
metabolism [17-19].   Because of their physiological importance [20], considerable work has 




focused on understanding the subtle differences between the two receptors, their ligands and 
signaling networks [21].  In solution, each receptor is capable of binding both insulin and IGF1 
with nM affinity [20, 22, 23].  Also, due to random receptor-dimer assembly in the endoplasmic 
reticulum, a significant fraction of native receptors in some cell types appear to be IR-IGF1R 
hybrids [24-27], further complicating the analysis of insulin and IGF1 binding kinetics.  
However, despite considerable literature describing IR, IGF1R and IR-IGF1R hybrid signaling in 
vitro, details of insulin and IGF1 binding to receptors in live cells at the single-molecule level 
remain elusive. 
Our results demonstrate that 2H3-RBL cells express detectable levels of both IR and 
IGF1R. We also show that insulin and IGF1 each bind to two distinct classes of sites on these 
cells and that both insulin and IGF1 compete with differing affinities for these binding sites.  
Finally, we demonstrate that dissociation of FITC-insulin from receptors is sensitive to the 
concentration of excess insulin available in solution, but is not sensitive to the initial FITC-insulin 
labeling concentration.  Taken together, our results suggest that, in addition to IR and IGF1R 
homodimers, hybrid IR-IGF1R heterodimers are present on the surface of 2H3-RBL cells and that 
a significant portion of insulin and IGF1 binding to these cells involves non-cognate receptors 
and IR-IGF1R hybrids. 
 
2. EXPERIMENTAL PROCEDURES 
2.1 Materials 
2H3-RBL cells were purchased from ATCC (Manassas, VA).  Human-recombinant-
insulin monovalently-labeled at the N-terminus with fluorescein isothiocynate (FITC-insulin) and 
human-recombinant-IGF1 were purchased from Invitrogen (Carlsbad, CA).  Insulin, bovine 
serum albumin (BSA), anti-rabbit biotin secondary antibody and FITC-avidin were purchased 
from Sigma (St. Louis, MO).  Anti-IRα, anti-IRβ and anti-IGF1Rα antibodies were purchased 




from Santa Cruz Biotech (Santa Cruz, CA).  Anti-Type I IgE receptor (FcεRI) antibody, FcεRIα 
was purchased from Upstate Cell Signaling Solutions (Billerica, MA).  Rhodamine 6G (R6G) 
was purchased from Allied Chemical (Vadodara, Gujarat, India).  Minimal essential medium 
(MEM) was purchased from Cellgro (Manassas, VA).  Fetal bovine serum (FBS), penicillin G, 
streptomycin and Fungizone were purchased from Gemini (Sacramento, CA).  
 
2.2 Preparation of cell samples 
2H3-RBL cells were maintained in plastic tissue culture dishes in MEM supplemented 
with 10% FBS, 200 mM L-glutamine, 10,000 U/mL penicillin G, 10 µg/mL streptomycin and 25 
μg/mL fungizone.  24-36 hr before experiments cells were seeded onto sterile #1.5 glass-bottom 
culture dishes, grown to approximately 50% confluence and, unless otherwise indicated, 
incubated in medium without FBS for at least 12 hr before use.  All cell labeling protocols were 
performed in phosphate-buffered saline pH 7.4 (PBS) containing 0.1% BSA (PBS-BSA), except 
as indicated.  All washes were in 1mL of PBS-BSA buffer for 30 sec. Before use, all antibodies, 
peptides and fluorescent probes were spun for 10 min at maximum speed in a tabletop 
microcentrifuge to remove aggregates.  Cell samples were immersed in 400 μL of buffer during 
FCS data acquisition, except as noted.  To reduce the effects of endocytosis on receptor 
internalization, all cell labeling and data acquisition were conducted at room temperature. 
 
2.3 Antibody labeling of receptors 
To label FcεRI, cells were incubated for 30 min with rabbit-derived primary antibody and 
washed 4 times.  Cells were then incubated for 15 min in 500 nM anti-rabbit biotin secondary 
antibody again followed by 4 washes.  Finally, cells were incubated in 250 nM FITC-avidin for 
15 min, followed by 4 washes.  To label the insulin receptor α-subunit (IRα), cells were serum 
starved or treated with 10 μM insulin for 1 hr or 10% FBS in MEM for 1 hr and then incubated 




for 30 min with rabbit-derived primary antibody and washed 4 times.  Cells were then incubated 
for 15 min in 500 nM biotin conjugated anti-rabbit secondary antibody again followed by 4 
washes.  Finally, cells were incubated in 250 nM FITC-avidin for 15 min, followed by 4 washes.  
To label the insulin receptor β-subunit (IRβ), cells were incubated for 30 min with biotin-
conjugated primary antibody followed by 4 washes and then incubated for 15 min in 250 nM 
FITC-avidin, followed by 4 washes.  To label IGF1R, cells were incubated for 30 min with 
rabbit-derived primary antibody specific against the α-subunit of IGF1R (IGF1Rα) and washed 4 
times.  Cells were then incubated for 15 min in 500 nM anti-rabbit biotin secondary antibody 
again followed by 4 washes.  Cells were then incubated in 250 nM FITC-avidin for 15 min, 
followed by 4 washes. 
 
2.4 Hormone labeling of receptors 
In FITC-insulin equilibrium binding experiments, cells were incubated in the indicated 
concentration of FITC-insulin for 30 min, followed by 4 washes.  For insulin and IGF1 
competition binding experiments, cells were simultaneously incubated in buffer solutions 
containing the indicated concentration of FITC-insulin and increasing amounts of either insulin or 
IGF1for 30 min, and then washed 4 times.  In experiments using cells pre-incubated with IGF1, 
cells were first incubated in the indicated concentration of IGF1 for 30 min and then in a 
combination of both the indicated amount of IGF1 and 250 nM FITC-insulin for 30 min, followed 
by 4 washes.  To measure FITC-insulin dissociation, cells were labeled with the indicated amount 
of FITC-insulin for 30 min, washed 4 times and then examined at the times indicated.  
Alternatively, to investigate the effects of aqueous insulin on FITC-insulin dissociation, cells 
were labeled with 250 nM FITC-insulin for 30 min, washed 3 times for 30 sec in 1 mL of buffer 
and then incubated in the indicated concentration of insulin for 30 min and washed 3 times.  To 
measure IGF1 dissociation, cells were labeled with 10 nM IGF1 for 30 min, washed 4 times and 




then incubated in buffer for the indicated time.  This was followed by labeling with 250 nM 
FITC-insulin for 30 min and 4 washes. 
 
2.5 FCS instrumentation 
FCS experiments were performed using a modified Nikon TE1000 inverted microscope 
equipped with a 100x, 1.25 NA oil-immersion objective, an Omnichrome Melles-Griot multi-line 
air-cooled argon ion laser, two Perkin Elmer single photon counting modules (SPCM-AQR-14) 
and an ALV-6010 digital hardware correlator.  This apparatus has been described in detail 
previously [28].  Based on FCS measurements of aqueous R6G diffusion, the 1/e2 radius ro of the 
laser excitation beam at the sample in our system was determined to be 241 nm (data not shown).  
To obtain the greatest signal-to-noise ratio while minimizing the effects of probe photobleaching 
on receptor density estimates and ligand binding kinetics, the intensity of the laser excitation 
beam at the sample was attenuated to  <100 μW using neutral density filters [29].  The laser 
excitation beam was focused on the apical cell membrane by adjusting the objective z-position to 
maximize detector count rates and minimize diffusional correlation times (τD) as described by 
Ries and Schwille [12].  Relevant portions of individual FCS traces were analyzed by weighted 
least-squares fitting of g(τ) to equation (3) to obtain estimates of the effective number of particles 
detected (N) and the diffusional correlation time (τD) for both receptor-bound and aqueous 
particles. 
 
2.6 Analysis of fluorescence intensity fluctuations 
All FCS data were analyzed using methods similar to those previously described by 
Schwille et al. [3], where the normalized fluctuation intensity autocorrelation function is defined 
as 




      (1) 
where F(t) is the mean fluorescence intensity fluctuation at time t and  
   (2) 
 is the corresponding fluorescence intensity fluctuation about the mean.  
Given a Gaussian excitation spot of 1/e2 radius ro and a substance with diffusion constant 
D, the autocorrelation function describing two-dimensional diffusion within the cell membrane is 
   (3) 
where N is the effective number of correlating particles detected in the illumination zone and 
    (4) 
is the characteristic time of correlation decay.  
 
2.7 Analysis of ligand- receptor interactions on live cells 
Analysis of FCS data showed that the number N of membrane bound particles detected 
depended on the concentration of receptor-specific fluorophore and competing ligands.  To 
evaluate the specific binding capacity and equilibrium dissociation constant KD of each 
fluorophore-conjugated ligand for receptors, data were fit to hyperbolic functions describing 
either one or two-site sequential binding. 
   (5) 
where N is the number of particles detected, c is the concentration of fluorophore-conjugated 
receptor-specific probe and N1, N2 are the maximum numbers of bound particles detected at 
saturating concentration of receptor-specific probe, exhibiting dissociation constants KD1 and KD2, 
respectively.  For single-site binding, N2 is fixed at zero. 
The density σ of receptors on the surface of live cells was calculated as 




    (6) 
When analyzing the competitive binding between two ligands, the concentration [I]1/2 of 
the competing ligand which gave 50% inhibition of probe binding was determined using 
   (7) 
where Nmax and No are the numbers of detected particles at the indicated concentration [L] of 
fluorophore-conjugated ligand as observed at zero and maximum concentrations of competing 
ligand, respectively. 
From [I]1/2 the equilibrium dissociation constant KI can be calculated according to the 
method of Cheng et Prusoff [30] as  
    (8) 
In ligand-dissociation experiments for both FITC-insulin and IGF1, data were fit to a 
single component exponential decay function 
  (9) 
where t is time and koff is the dissociation rate constant. 
 
2.8 Presentation of Results 
Each data point shown in figures represents the combined result of FCS measurements 
from 14-20 individual 2H3-RBL cells.  Values presented in figures, text and tables, excluding 
Figure 4 and Figure 5a, are the arithmetic mean ± SD.  To improve visual clarity, Figure 4 and 
Figure 5a show the mean ± SEM. 
 
 





3.1 Binding of fluorescent probes to live cells 
We used FCS to analyze the dynamics of peptide-conjugated fluorescent probes in 
solution and when bound to receptors on the membranes of live 2H3-RBL cells.  τD values for 
these probes in solution correspond to lateral diffusion constants of approximately 5x10-7 cm2s-1 
as is appropriate for small proteins in solution (Figure 2.1).  When bound to receptors on live 
2H3-RBL cells the fluorescence emission of the FITC-conjugated receptor-specific probes was 
localized to the cell-surface and detected particles exhibited τD that correspond to lateral diffusion 
constants of between 10-9 cm2s-1 and 10-10 cm2s-1 as is appropriate for cell-surface receptors 
(Figure 2.1).  Receptors on live cells labeled with either FITC-insulin or a sandwich of IR-
specific antibody, biotinylated-secondary antibody and FITC-avidin had similar diffusion times 
while antibody-labeled Fcε receptors exhibited somewhat slower diffusion.  After an initial 
(~10sec) illumination phase to deplete immobile particles [3, 31], the photon count rates from 
both avalanche photodiodes during live cell labeling experiments were steady, indicating that 
there was no appreciable photobleaching of FITC-insulin over the time-scale of these experiments 
(data not shown).   
To test the specificity of our probes, we performed FCS measurements on cells incubated 
with FITC-avidin while omitting either primary or secondary antibody or both.  No appreciable 
surface-localized fluorescence was observed under these conditions (data not shown).  
 
3.2 Determination of FcεRI, IR and IGF1R cell-surface densities 
2H3-RBL cells are known to express both FcεRI [32] and IR [33].  Figure 2.2a shows 
correlation data obtained from live 2H3-RBL cells labeled with increasing concentrations of 
primary antibody specific for an external epitope of FcεRI.  Non-linear least-squares analysis of 
these data using a single-site binding model showed that the FcεRI-specific antibody binds to an 




estimated 540 receptors μm-2 with KD of 61 nM (Table 2.1). A total of 170,000 FcεRI per cell was 
calculated from the receptor surface density assuming 2H3-RBL cells each have an average 
surface area of 314 μm2 [32]. This is consistent with previous estimates of between 200,000-
300,000 receptors per cell for this cell type [32, 34-37]. 
Two different primary antibodies specific for external epitopes of either IRα or IRβ, 
respectively, were then used to determine the density of IR on the surface of live 2H3-RBL cells.  
Measurements made with both primary antibodies resulted in similar estimates of IR surface 
density (Figure 2.2b and c).  Use of the IRα-specific antibody yielded 190 receptors μm-2 or 
60,000 per cell, while the IRβ-specific antibody yielded 196 receptors μm-2 or 62,000 per cell 
(Table 2.1).  However, despite providing similar estimates of IR density, the two IR-specific 
antibodies exhibited distinct KD.  The IRα-specific antibody appeared to bind receptors with KD 
of 23 nM, while the IRβ-specific antibody appeared to bind with KD of 163 nM (Table 2.1). 
We also estimated the density of IGF1R on these cells using an antibody specific for 
IGF1Rα.  This antibody appeared to bind 161 receptors μm-2 or 51,000 per cell with a KD of 2 nM 
(Figure 2.2d and Table 2.1). 
 
3.3 Equilibrium binding of FITC-insulin to live cells 
To evaluate the binding of insulin to IR on live cells, we used a commercially available 
N-terminally labeled FITC-insulin.  In contrast to the binding of receptor-specific antibodies, 
equilibrium binding of FITC-insulin appeared to fit best to a two-site sequential model (Figure 
2.3a).  Scatchard analysis of FITC-insulin binding also showed a curvilinear ‘concave up’ pattern 
indicating two classes of FITC-insulin binding sites (Figure 2.3b). Using least-squares analysis, 
we determined the KD of the two classes of FITC-insulin binding sites to be 0.11 nM and 75 nM 
with surface densities of 49 sites µm-2 and 124 sites µm-2, respectively (Table 2.2).  The total 




number of FITC-insulin binding sites identified in these experiments was approximately 54,000 
per cell.  
FITC-insulin binding to receptors on 2H3-RBL cells was almost completely blocked by 
pre-incubating cells in medium containing 10% FBS or 10 μM insulin (Table 2.3), treatments 
which had no effect on the binding of the IRα antibody (Figure 2.2b).  Binding of 250 nM FITC-
insulin was also partially blocked by pre-incubation of cells with between 0.1-10 nM IGF1 (Table 
2.3).  The diminished binding of FITC-insulin to cells that have been pre-incubated with 
increasing concentrations of IGF1 is assumed to result from occupancy of the FITC-insulin 
binding sites by IGF1. This suggests that at least 67 ± 28 µm-2 of the low affinity FITC-insulin 
binding sites, approximately 21,000 ± 9,000 per cell, are able to bind IGF1 with KD of 0.14 ± 
0.04 nM (Figure 2.4).  
 
3.4 Insulin and IGF1 competitive binding to live cells 
When cells are labeled simultaneously with FITC-insulin and either insulin or IGF1, 
equilibrium competition for available binding sites is observed (Figure 2.5a and b).  In such 
competition binding experiments using a probe concentration of 0.1 nM FITC-insulin, insulin 
competed with KI of 0.09 nM (Table 2.4).  However, the apparent KI of insulin for FITC-insulin 
binding sites decreased when probed with increasing concentrations of FITC-insulin. 
Alternatively, IGF1 competed with 0.1 nM FITC-insulin for binding sites with a KI of 9.4 nM 
(Table 2.5). Although, similar to insulin, the apparent KI of IGF1 for FITC-insulin binding sites 
decreased when probed with increasing concentrations of FITC-insulin.    
 
3.5 Dissociation rates of FITC-insulin and IGF1 from live cells 
The dissociation of FITC-insulin from the surface of 2H3-RBL cells in the absence of 
excess solution phase insulin was monitored by measuring the number of particles remaining 




bound to cells every 3 min for 2 hr.  Figure 2.6a shows that, when incubated in insulin-free PBS-
BSA buffer, cells labeled with FITC-insulin concentrations ranging from 1-100 nM behaved 
similarly and exhibited koff values between 0.014 min-1  and 0.017 min-1 (Table 2.6).  
However, dissociation of FITC-insulin was sensitive to the concentration of excess 
insulin available in solution.  Cells labeled with 250 nM FITC-insulin were incubated for 30 min 
in the indicated concentrations of excess insulin, then washed and observed (Figure 2.6b).  It 
appears that the rate of FITC-insulin dissociation increased in the presence of unlabeled insulin at 
concentrations below 10-8 while, at insulin concentrations greater than  10-8 M, the rate of FITC-
insulin dissociation decreased. 
Dissociation of IGF1 was monitored by examining the partial blocking of FITC-insulin 
binding at various times after pre-incubating cells with IGF1 (Figure 2.6c).  Diminished binding 
of 250 nM FITC-insulin after pre-incubating cells with 10 nM IGF1 is assumed to result from 
occupancy of FITC-insulin binding sites by IGF1 as was discussed in Section 3.3.  Using this 
method, we estimated that the koff of IGF1 from receptors on live 2H3-RBL cells is 0.013 min-1 
(Table 2.6). 
  
3.6 Estimated association rates for insulin and IGF1 binding to live cells 
Our results provide experimentally-determined values for either KD or KI , and koff for 
FITC-insulin or insulin and IGF1 reversibly binding to receptors on 2H3-RBL cells. From these 
data we estimated the rate of association kon for each ligand binding to both high and low affinity 
sites.  The kon for high and low affinity FITC-insulin binding sites were estimated to be 1.4x108 
M-1min-1 and 2x105 M-1min-1, respectively.  Alternatively, the kon of IGF1 to high affinity IGF1 
binding sites identified after pre-incubation with IGF1 was estimated to be 7.1x109 M-1min-1, 
while the kon of IGF1 to low-affinity IGF1 binding sites identified in competitive labeling 
experiments between IGF1 and FITC-insulin was estimated to be 1.4x106 M-1min-1.   




   
4. DISCUSSION 
 The present work emphasizes the utility of FCS for the quantitative examination of 
membrane receptor ligand binding in living cells at the single molecule level [14, 15, 34].  
Localization of fluorophore-conjugated ligand fluorescence to the cell membrane, specificity of 
ligand binding, and differences in lateral diffusion between solution-phase and membrane 
localized fluorophore-conjugated ligands allows specific examination of fluorophore-conjugated 
ligands bound to membrane receptors even in the presence of solution-phase fluorophore-
conjugated ligand [3].   
 In the present study, use of antibodies specific against either α or β subunits of IR led to 
initial estimates of between 190-196 receptors µm-2 or approximately 60,000 receptors per cell. 
Labeling of receptors with FITC-insulin led to a slightly lower estimate of approximately 54,000 
total receptors.  This is similar to previous work by Rigler and coworkers who estimated the 
density of IR on live human renal cells to be approximately 200 µm-2 [38].  Estimation of IGF1R 
numbers using an IGF1Rα specific antibody also identified 161 receptors µm-2 or 51,000 per cell.  
However, FCS measurements enumerate separately diffusing species binding particular 
fluorescent ligands, hence apparent numbers of IR and IGF1R estimated using anti-IR or anti-
IGF1R antibodies, respectively, also include IR/IGF1R hybrids. Thus, it is likely that neither IR 
nor IGF1R density are actually this high [27].  We also suggest that similar overestimation of IR 
and IGF1R occurs when using fluorophore-conjugated peptide ligands such as FITC-insulin, 
which in addition to binding cognate receptors, also bind with measurable affinity to non-cognate 
and hybrid IR-IGF1R.  
 Multiple lines of research have shown that the binding of insulin to IR is negatively 
cooperative in vitro [20, 39] with insulin binding to IR at two sites, each with a distinct KD [40, 
41].  Similarly, our results show that FITC-insulin binds two classes of sites on 2H3-RBL cells 




and exhibits an upward curving Scatchard plot.  This curvilinear Scatchard plot is commonly seen 
during examination of insulin binding and was previously observed by Zhong and coworkers 
when examining rhodamine-labeled insulin (Rh-insulin) binding to human renal cells using FCS 
[42].  These investigators attributed such curvilinear Scatchard plots either to the negative 
cooperative binding of insulin to IR or to separate classes of receptors with differing affinities for 
insulin.  However, FCS monitors the number of separately diffusing species and is somewhat 
insensitive to the absolute brightness of each species.  Once a FITC-insulin or Rh-insulin 
molecule binds to an individual IR, the binding of subsequent fluorophore-labeled insulin 
molecules to this IR, despite changing the absolute magnitude of fluorescence fluctuations as the 
receptor enters and exits the interrogation volume, has only a limited effect on the normalized 
autocorrelation function [3].  With this in mind, we suggest that the majority of receptors 
observed in the present work on live 2H3-RBL cells that bind FITC-insulin with low affinity, and 
those observed by Zhong and coworkers that bind Rh-insulin with low affinity [42], may not be 
IR but are more likely either IGF1R or IR-IGF1R hybrids. 
Negative cooperativity in insulin binding to IR was apparent from our measurements of 
FITC-insulin dissociation.  Our results demonstrate that FITC-insulin dissociation varied with the 
concentration of excess insulin available in solution.  FITC-insulin dissociation initially 
accelerated with increasing concentrations of excess insulin, but then decreased at insulin 
concentrations above 10-8 M.  However, in the absence of excess insulin, the dissociation rate of 
FITC-insulin was independent of the initial labeling concentration.  Acceleration of ligand 
dissociation in response to excess solution-phase ligand can indicate negatively-cooperative 
binding and, while not necessarily relevant physiologically, the effects of insulin concentrations 
above 10-8 M provide insight into the mechanism of insulin binding to IR and support the 
harmonic oscillator model of insulin and IGF1 binding proposed by Kiselyov and coworkers [17]. 




 Our results also demonstrate that FITC-insulin, insulin and IGF1 compete for binding to 
available receptors on live 2H3-RBL cells.  At a FITC-insulin labeling concentration of 0.1 nM, 
approximately equal to FITC-insulin’s high-affinity site KD, the binding of FITC-insulin and 
insulin are quite similar, indicating that conjugation of fluorescein to insulin does not affect IR 
binding, and values of KI obtained for IGF1 competing with 0.1 nM FITC-insulin agree with 
existing literature showing that IR can bind IGF1 with nM affinity [20].  At higher levels of 
receptor occupancy, obtained by increasing the labeling concentration of FITC-insulin, the 
affinities of insulin and IGF1 relative to FITC-insulin appear to decrease.  This may result from 
FITC-insulin binding to a combination of IR, IGF1R and IR-IGF1R hybrids when used at higher 
labeling concentrations or, alternatively, may result from multivalent binding of FITC-insulin to 
receptors. 
 Like IR, IGF1R exhibits complex ligand binding kinetics [43, 44], binding its cognate 
ligand IGF1 strongly, but also binding insulin with nM affinity [20]. Evidence also suggests that 
IR-IGF1R hybrids, much like IGF1R, bind IGF1 strongly, but can also bind insulin with  nM 
affinity [45-48].  We found that 67 sites µm-2 of the 124 sites μm-2 that bind insulin with low 
affinity also bind IGF1 with high affinity.  This suggests that these receptors are likely not IR, but 
rather are either IGF1R or IR-IGF1R hybrids.  However, the total number of receptors identified 
using FITC-insulin on 2H3-RBL cells was only slightly more than half the combined number of 
receptors identified using IR- and IGF1R-specific antibodies, suggesting that a substantial portion 
of these receptors are in fact IR-IGF1R hybrids.  
The current model describing the formation of IR and IGF1R homodimers and IR-IGF1R 
hybrids assumes that IR and IGF1R monomers randomly associate to form dimers within the 
endoplasmic reticulum [27].   This model predicts that the ratio (R) of IR monomers to IGF1R 
monomers produces IR homodimers, IR-IGF1R hybrids and IGF1R homodimers at relative 
fractions of R2:2R:1 [27].  If the results of receptor-specific antibody experiments are used as a 




first approximation of the ratio of IR monomers to IGF1R monomers on these cells, this model 
predicts that nearly two thirds of the species identified as either IR or IGF1R are actually IR-
IGF1R hybrids.  Since receptor-specific labeling indicated the surface density of IR monomer-
containing species is 190 μm-2, this suggests that only 63 μm-2 of these species are actual IR 
homodimers, which is similar to the 49 receptors μm-2 on these cells that bind FITC-insulin with 
high affinity.  This model also predicts an IGF1R homodimer density of approximately 54 μm-2, a 
value similar to the 67 receptors µm-2 we identified that bind IGF1 with high affinity.  Given the 
known similarity between the KD’s of IGF1R and IR-IGF1R hybrids for IGF1, we anticipated that 
nearly all of the 161 receptors μm-2 identified with IGF1R specific antibody would have bound 
IGF1 with high affinity.  However, this discrepancy is likely the result of our inability to directly 
observe IGF1 binding.  Taken together, our results suggest that the ratios of IR to IR-IGF1R 
hybrids to IGF1R on live 2H3-RBL cells is between 1:2:1 and 2:3:1 and are generally consistent 
with random association of IR and IGF1R monomers in the endoplasmic reticulum. 
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6. FIGURE LEGENDS 
 
Figure 1: Normalized autocorrelation functions for fluorescent probes in solution and 
bound to receptors on the surface of live 2H3-RBL cells. [●] FITC-insulin (aqueous), [○] FITC-
avidin (aqueous), [Δ] FITC-insulin (live cells), [▼] FITC-avidin (bound to IR specific antibody 
on live cells), [■] FITC-avidin (bound to FcεRI specific antibody on live cells). To improve 
clarity not all time points are shown. 
 
Figure 2: Equilibrium binding of receptor specific antibodies to live 2H3-RBL cells. 
Binding of FITC-avidin to cells labeled with increasing concentrations of, A) [●] FcεRI specific 
antibody, B) [●] IRα-specific antibody, also shows that pre-incubation of cells with [▲] 10 μM 
insulin or medium containing [□] 10% FBS has no effect on antibody labeling of IR, C) [●] IRβ-
specific antibody, or D) [●] IGF1Rα-specific antibody before labeling with biotinylated 
secondary antibody.  
 
Figure 3: A) [●] Equilibrium binding of FITC-insulin to receptors on the surface of 
serum starved 2H3-RBL cells was fit to a two-site sequential model. B) [●] Scatchard analysis of 
FITC-insulin binding displays a concave-up curvilinear pattern.  
 
Figure 4: [●] Indirect observation of IGF1 binding to live 2H3-RBL cells. Pre-incubation 
with increasing concentrations of IGF1 reduced the apparent binding of 250 nM FITC-insulin to 
live cells. 
 
Figure 5: Competitive binding of insulin and IGF1 to receptors on 2H3-RBL cells. A) 
Competitive binding of insulin and [●] 0.1 nM, [○] 1 nM,  [▼] 10 nM, or [Δ] 50 nM FITC-
insulin to receptors on 2H3-RBL cells. B) Competitive binding of IGF1 and [●] 0.1 nM, [○] 1 
nM, or  [▼] 10 nM FITC-insulin to receptors on 2H3-RBL cells. 
 
Figure 6: Dissociation of insulin and IGF1 from receptors on 2H3-RBL cells. A) 
Dissociation of [●] 1 nM, [○] 10 nM,  or [▼] 100 nM FITC-insulin from receptors on live 2H3-
RBL cells in the absence of excess aqueous insulin. For each condition, every data point shown is 
from a different cell. B) [●] Effects of excess aqueous insulin on the dissociation of FITC-insulin 
from live 2H3-RBL cells. The koff of FITC-insulin initially increases with increasing insulin 
concentrations but then, at concentrations of insulin >10-8 nM, decreases. C) [●] The dissociation 
of 10nM IGF1 is shown. Data points represent the reduction in the binding of 250 nM FITC-
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Table 2.1: Surface density of IR, IGF1R and FcεRI on 2H3-RBL cells and binding parameters of the primary antibody used to identify each 
receptor. 
Receptor Antibody N1  σ (receptors μm-2) Total receptors2  KD (nM)3 
IR  IRα  34.6±1.2 190±7   60,000±2,000    23±4 
IR  IRβ  35.8±4.5 196±25   62,000±8,000              163±56 
IGF1R  IGF1Rα 29.3±1.2 161±7   51,000±2,000      2±1 
FcεRI  FcεRIα  98.4±19.6 540±108            170,000±34,000                61±23 
1N is the effective number of particles detected in the FCS laser-spot at saturating concentrations of primary receptor-specific antibody. 
2Value for total receptors per cell assumes the surface area of a 2H3-RBL cell is 314μm-2 [32]. 














Table 2.2: Equilibrium binding of FITC-insulin to receptors on the surface of live 2H3-RBL cells. 
Binding Site  N1   σ (receptors μm-2) Total receptors2  KD (nM)3 
1   9.0±1.1    49±6   15,000±2,000  0.11±0.05 
2             22.6±1.4  124±8   39,000±3,000     75±23 
1N is the upper limit for detected particles for sites 1 and 2. 
2Value for total receptors per cell assumes the surface area of a 2H3-RBL cell is 314μm-2 [32]. 

















Table 2.3: Reduced binding of FITC-insulin to receptors on 2H3-RBL cells after pre-incubation with insulin, FBS or IGF1. 
Treatment  N1   Diff (N)2 
None   24.8±5.1  NA 
Insulin (10μM)    2.0±1.6  22.8±5.1 
FBS (10%)    4.6±1.0  20.2±5.1     
IGF1 (0.1nM)  19.8±1.6    5.2±5.1 
IGF1 (1nM)  14.1±3.1  10.9±5.1 
IGF1 (10nM)  12.9±0.8  12.1±5.1 
1N is the number of particles detected after labeling with 250nM FITC-insulin. 














Table 2.4: Competitive binding of insulin and FITC-insulin to receptors on live 2H3-RBL cells. 
[FITC-insulin] (nM) I1/2 (nM)1 KI (nM)2 Nmax3   No4 
0.1  0.18±0.02 0.09±0.01   5.9±0.1 1.1±0.1 
1    5.4±1.6 0.54±0.16   9.1±0.3 1.3±0.3 
           10  47.4±3.4 0.52±0.04 10.4±0.1 1.0±0.1 
           50   590±250 1.29±0.55 12.4±0.2 2.1±0.8 
1I1/2 values were obtained by fitting binding data for insulin concentrations between 10-4 and 105 nM to equation (7). 
2Values for KI were obtained from I1/2 using equation (8). 
3Nmax is the apparent number of particles detected in the absence of competing insulin. 














Table 2.5: Competitive binding of IGF1 and FITC-insulin to receptors on live 2H3-RBL cells. 
[FITC-insulin] (nM) I1/2 (nM)1 KI (nM)2 Nmax3  No4 
0.1     21.1±8.1   9.4±3.6   5.9±0.1 0.7±0.4 
1   143.7±72.4 10.9±5.5   9.6±0.2 0.5±0.1 
           10             1727.6±N.A. 14.5±N.A. 10.7±0.5    1±N.A. 
1I1/2 values were obtained by fitting binding data for IGF1 concentrations between 10-3 and 103 nM to equation (7).  
2Values for KI were obtained from I1/2 using equation (8). 
3Nmax is the apparent number of particles detected in the absence of competing IGF1. 















Table 2.6: Rate of FITC-insulin and IGF1 dissociation from receptors on 2H3-RBL cells. 
Ligand  Concentration (nM) koff (min-1)  t1/2 (min)1 
FITC-insulin  1  0.014±0.001  50±4  
FITC-insulin  10  0.017±0.001  41±4 
FITC-insulin  100  0.015±0.001  46±4 
IGF1   10  0.013±0.004  52±16 













Chapter III: Peter W. Winter performed fluorescence correlation spectroscopy shown in 
Figure 3 and fluorometric assessment of live cell lipid order shown in Figure 4 
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We have examined the association of insulin receptors (IR) and downstream signaling molecules 
with membrane microdomains in rat basophilic leukemia (RBL-2H3) cells following treatment 
with insulin or tris(2-pyridinecarbxylato)-chromium(III) (Cr(pic)3).  Single-particle tracking 
demonstrated that individual IR on these cells exhibited reduced lateral diffusion and increased 
confinement within 100 nm-scale membrane compartments after treatment with either 200 nM 
insulin or 10 μM Cr(pic)3. These treatments also increased the association of native IR, 
phosphorylated insulin receptor substrate 1 and phosphorylated AKT with detergent-resistant, 
cholesterol-containing, membrane microdomains of characteristically high buoyancy.   Confocal 
fluorescence microscopic imaging of Di-4-ANEPPDHQ labeled RBL-2H3 cells also showed that 
plasma membrane lipid order decreased following treatment with Cr(pic)3 but was not altered by 
insulin treatment.  Fluorescence correlation spectroscopy demonstrated that Cr(pic)3 did not affect 
IR cell-surface density or compete with insulin for available binding sites.  Finally, Fourier 
transform infrared spectroscopy indicated that Cr(pic)3 likely associates with the lipid interface in 
reverse micelle model membranes.  Taken together, these results suggest that activation of IR 
signaling by both insulin and Cr(pic)3 involves retention of IR in specialized nanometer-scale 
membrane microdomains but that the insulin-like effects of Cr(pic)3 are due to changes in 
membrane lipid order rather than to direct interactions with IR. 
 








To better understand how chromium-containing compounds mediate insulin receptor (IR) 
signaling, we compared the effects of insulin and tris(2-pyridinecarbxylato)-chromium(III) 
Cr(pic)3 on the lateral motions of individual IR diffusing on the surface of live rat basophilic 
leukemia (RBL-2H3) cells and on the association of IR and downstream targets with chemically-
isolated, cholesterol-containing plasma membrane microdomains of characteristically high 
buoyancy (1).  We also examined the effect of Cr(pic)3 on the density of native IR on the surface 
of live RBL-2H3 cells using fluorescence correlation spectroscopy (FCS) and on live RBL-2H3 
cell membrane lipid-order using ratiometric confocal fluorescence imaging of the phase-sensitive 
lipid probe Di-4-ANEPPDHQ.  
Our results demonstrate that cell treatment with either insulin or Cr(pic)3 reduces both individual 
IR lateral diffusion and the size of IR-containing cell-surface compartments and causes the 
accumulation of IR, phosphorylated IRS-1 (pIRS-1) and phosphorylated AKT (pAKT) in 
relatively buoyant, detergent-resistant membrane microdomains.  However, while treatment with 
Cr(pic)3 significantly decreases cell-surface membrane lipid order on intact cells, treatment with 
insulin does not.  Additionally, FCS suggests that Cr(pic)3 does not interact directly with IR or 
affect IR cell-surface density.  Together, these results demonstrate that insulin and Cr(pic)3 
increase association of IR and downstream targets with specialized, cell-surface membrane 
microdomains and suggest that the insulin-like activity of Cr(pic)3 is likely due to decreases in 
membrane lipid order rather than to direct interactions with IR. 
Multiple lines of research indicate that IR and downstream targets interact with cholesterol-
containing membrane microdomains during insulin-mediated IR signaling (2-7).  Specifically, 
investigators have demonstrated that cholesterol-containing membrane microdomains facilitate IR 
signaling by organizing IR and downstream targets of phosphorylated insulin receptor (pIR) such 
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as TC-10(6), IRS-1 (7), PIP2 (8) and the CAP/Cbl complex(9).  Additionally, chromium-
containing compounds are known mediators of IR function and chromium supplementation has 
been shown to improve insulin sensitivity in multiple studies (10-16). Specifically, there is an 
increase in the translocation of GLUT4 to the plasma membrane in the skeletal muscle of obese, 
hyperinsulinemic, JCR-LA corpulent rats in response to Cr(pic)3 (17). Moreover, CHO cells 
expressing IR exhibit increased IR phosphorylation in response to treatment with various 
chromium(III) compounds (18).  A small number of human trials have shown improvements in 
both insulin sensitivity and oxidative stress tests after treatments with Cr(pic)3 (11, 12, 19-21).  
Despite the well-described effects of chromium supplementation on insulin-mediated IR 
signaling, the mechanism underlying these effects remains unclear.  It has been suggested that 
chromium supplementation increases the number of cell-surface IR (22).  However, this is not 
evident from the results of other studies, including one where chromium supplementation had no 
effect on IR numbers or the transcription of insulin-like substrate 1 (IRS-1) mRNA in skeletal 
muscle tissue of male KK/H1J mice (15).  Alternatively, it has also been suggested that the 
activity of chromium-containing compounds either involves a small, chromium-binding 
oligopeptide known as LMWCr or chromodulin (23, 24) which is postulated to bind both 
chromium and insulin-IR complexes, increasing the tyrosine-kinase activity of IR (23), or that 
chromium-containing compounds, including Cr(pic)3, decrease membrane lipid order, rather than 
having direct effects on IR or IR-binding proteins (14, 25). 
Materials and Methods 
Materials 
Minimum Essential Medium (MEM) with Earle’s Balanced Salts was purchased from Thermo 
Scientific (Logan, Utah).  Fetal bovine serum (FBS) was purchased from Gemini BioProducts 
(Woodland, CA).  Insulin from bovine pancreas, anti-phospho(Tyr972)-insulin receptor, methyl-β-
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cyclodextrin (MβCD), FITC-avidin, and anti-rabbit-biotin were purchased from Sigma-Aldrich 
(St. Louis, MO).  Anti-insulin receptor-β (C-19), anti-insulin receptor-α (N-20), anti-
phospho(Ser474)-AKT and anti-phospho(Tyr632)-IRS-1  were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA).  Colloidal gold (40 nm) was purchased from Ted Pella, Inc 
(Redding, CA).  The phase-sensitive aminonaphthylethenylpyridinum-based dye Di-4-
ANEPPDHQ was purchased from Invitrogen (Carlsbad, CA). Complete mini protease inhibitor 
cocktail tablets were purchased from Roche (Indianapolis, IN).  35mm, #1.5 glass bottom petri 
dishes were purchased from Willco Wells (Amsterdam, Netherlands).  Cr(pic)3 was synthesized 
and characterized as previously described(26, 27). 
Cell culture 
2H3 rat basophilic leukemia (RBL-2H3) cells were maintained in cell medium that included 
MEM supplemented with Earle’s Balanced Salts and 10% FBS, 200 mM L-glutamine, 10,000 
U/mL penicillin G, 10 µg/mL streptomycin and 25 μg/mL Fungizone (Gemini BioProducts). In 
some experiments, cells were incubated in supplemented MEM without FBS overnight to remove 
a source of insulin and other growth factors.  
Single particle tracking of individual insulin receptors 
Lateral diffusion of individual IR on live RBL-2H3 cells was measured using slight modifications 
of established protocols (28).  40 nm nanogold particles were stabilized with the lowest possible 
concentration of bovine serum albumin (BSA) containing a small amount of anti-IRα antibody.  
The amount of anti-IRα antibody used in the preparation of the gold complexes was adjusted to 
the lowest possible concentration that resulted in binding of approximately 5-10 visible gold 
particles on the apical surface of each cell.  Binding of gold-anti-IRα conjugates to cells was 
preventable by pre-labeling cells with an excess of unconjugated anti-IRα antibody.  In some 
experiments, cells were treated with 200 nM insulin for 30 min after labeling of IR with an IR α-
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subunit specific antibody or with 10 μM Cr(pic)3 for 12 h before labeling.  Individual 
nanoparticles were imaged by differential interference contrast with a 1.4 NA, 63x objective in a 
Zeiss Axiovert 135 microscope.  Images were acquired using a Dage IFG-300 camera and were 
recorded for two minutes (3600 frames) at approximately 30 nm/pixel under the control of 
Metamorph 6 imaging software (Molecular Devices).  The trajectories for individual gold 
particles were segmented into domains by examining the variance in particle position over 
various time windows as previously described (29, 30).  Diffusion coefficients and the size of 
compartments accessed by individual IR were also determined using established procedures (29-
31).   
Isolation of plasma membrane rafts 
RBL-2H3 cells were incubated with either 200 nM insulin for 1 hr at 37°C, with 10 μM Cr(pic)3  
overnight at 37°C or with both 10 μM Cr(pic)3 overnight and then 200 nM insulin for 1 hr at 
37°C.  To isolate membrane rafts from RBL-2H3 cells, 5x107 cells were washed two times with 
phosphate-buffered saline, pH 7.2 (PBS) and lysed for 5-10 minutes on ice in 1 mL of a buffer 
containing 25 mM MES, 150 mM NaCl, 2mM EDTA, 0.25% Triton-X100, and a protease 
inhibitor cocktail including aprotinin, leupeptin, EDTA, and phenylmethylsulfonyl fluoride 
(Roche).  A low speed 300x g spin was used to remove cell nuclei and large cell debris.  
Supernatant from this spin (1 mL), which contained plasma membrane fragments, was then 
combined with an equal volume of 80% sucrose containing 0.25% Triton-X100 and the protease 
inhibitors to produce a 40% sucrose solution.  A discontinuous sucrose gradient containing equal 
volumes of 10-80% sucrose was created with the sample in 40% sucrose layered within this 
gradient.  The gradient was loaded into a Beckman SW-41 swinging bucket rotor and spun at 
175,000x g for 20 hr at 4°C.  After the spin, eighteen 650 μL fractions were carefully collected 
from the top of the gradient downward.  A 50 μL aliquot from each fraction was diluted 1:1 with 
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95% SDS and 5% β-mercaptoethanol.   Proteins of interest from fractions containing  >40% 
sucrose or <40% sucrose were identified by Western blotting as previously described (32), and 
the relative amount of each protein was determined using a Bio-Rad GS-800 calibrated 
densitometer. Sucrose concentrations were determined from refractive indices using a Bausch and 
Lomb refractometer.  In some experiments, cells were treated for 1hr at 37°C with 10 mM 
methyl-β-cyclodextrin (MβCD),  a cholesterol sequestering agent (33), in serum-free medium 
after incubation with either insulin or Cr(pic)3.  
Fluorescence correlation spectroscopy measurements of cell-surface insulin receptor density and 
insulin binding 
RBL-2H3 cells were seeded onto sterile dishes and treated with 10 μM insulin for 1 h or 10 μM 
Cr(pic)3 overnight. Cells were then sequentially washed and labeled with anti-IRα (N-20) rabbit 
IgG (SantaCruz Bio) for 30-40 min, anti-rabbit-biotin IgG (Sigma) for 20 min, and FITC-avidin 
for 15 min, washed and then submerged in 1 mL buffer. Alternatively, cells were labeled with 
FITC-insulin (Invitrogen) and then washed 4 times for 30 secs in 1mL of buffer. Fluorescence 
correlation spectroscopy (FCS) experiments were performed using a modified Nikon TE1000 
inverted microscope equipped with a 100x, 1.25NA oil-immersion objective, an Omnichrome 
Melles-Griot multi-line air-cooled argon ion laser operating at 514.5 nm, 570/32 nm band pass 
filters, two PerkinElmer photon counting modules (SPCM-AQR-14) and an ALV-6010 digital 
hardware correlator (34).  The 1/e2 radius of the excitation beam at the sample was determined to 
be 241nm from measurements of aqueous rhodamine-6G diffusion (data not shown). Samples 
were illuminated briefly (~10sec) before acquisition of data to irreversibly photobleach immobile 
particles (39).  Data were then collected for 20 sec during which time the average fluorescence of 
the sample remained relatively constant (data not shown).  Correlation data were analyzed 
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according to established procedures using Igor Pro 5.05A to yield the surface density of diffusing  
FITC-insulin particles in the laser beam (35-38).    
Evaluation of RBL-2H3 cell plasma membrane lipid order 
RBL-2H3 cells were seeded onto sterile dishes and treated with 200 nM insulin for 1hr or with 
0.1, 1.0 or 10 μM Cr(Pic)3 overnight. In some experiments, cells were treated with 10mM MβCD 
for 1hr to deplete membrane cholesterol (40).  After the various treatments, cells were labeled 
with 1.0 μM Di-4-ANEPPDHQ for 30 minutes, washed and immersed in buffer for imaging. 
Confocal fluorescence images were acquired using an Olympus IX-71 inverted microscope 
equipped with a 60x, 1.2NA water-immersion objective and a FV 300 confocal scanning unit. 
Cell samples were illuminated with a 488 nm laser.  Fluorescence emission, split between 
detector channels 1 and 2 using a 570 nm dichroic mirror, was collected simultaneously in 
channel 1 up to 530 nm and in channel 2 using a 605 nm band-pass filter. All images were 
collected at identical instrument and detector settings with the exception of the laser excitation 
power which was adjusted between experiments due to slight variations in labeling efficiency.  
Background correction and the background-corrected ratio of fluorescence emission at 605 nm to 
that at 530 nm (red/green) were calculated using NIH Image J 1.42i. 
Evaluation of Cr(pic)3 in reverse-micelle model-membranes using Fourier transformed infrared 
spectroscopy 
Microemulsion samples were prepared from 5 mM Cr(pic)3 in 2.5% D2O in H2O (pH 7.2) and 0.2 
M AOT in isooctane at ([H2O]/[AOT]) ratios (wo) of 6, 10 and 18 using established procedures 
(41).  As controls, microemulsions containing 100 mM sodium picolinate (Na(pic)) at pH 7.5 and 
samples containing 5 mM Cr(pic)3 in H2O and 0.2 M AOT in isooctane were also prepared by 
similar methods.  All samples examined were nominally transparent.  FTIR spectra were recorded 
on a Nicolet Magna 760 spectrophotometer.  Samples were examined in BaF2 2 mm IR 
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microcuvettes with Teflon spacers of 0.050 mm thickness. Samples prepared in H2O were 
subtracted from samples containing 2.5 % D2O in H2O. Emission peak wavelengths are presented 
in (nm) and represent the average of 128 scans with 1.0 cm-1 resolution.   
Results 
Insulin receptors exhibit restricted lateral diffusion in response to insulin or Cr(pic)3 
In SPT experiments individual IR on RBL-2H3 cells labeled with anti-IR antibody-colloidal gold 
complexes exhibit slower lateral diffusion and are retained in small, nanometer-scale plasma 
membrane compartments in response to insulin or Cr(pic)3 (Table 3.1, Figure 3.1). The average 
lateral diffusion coefficient of IR in cells incubated in serum-free medium for at least 12 h is 
approximately 1x10-11cm2s-1 and is slowed following exposure to insulin or Cr(pic)3 to about 
5x10-12cm2s-1, although these values were not statistically different.  However, the size of the 
compartments accessed by individual IR decreased significantly from 216±23 nm to 113±16 nm 
and 119±19 nm after insulin and Cr(pic)3 treatments, respectively (Table 3.1 and Figure 3.1). 
Treatment with both insulin and Cr(pic)3 together also appeared to reduce the size of 
compartments accessed by IR to 98±16 nm although this did not differ significantly from the 
effect of insulin or Cr(pic)3 treatments alone. 
Insulin receptors associate with detergent-resistant membrane microdomains after exposure to 
insulin or Cr(pic)3 
Treatment of RBL-2H3 cells with 200 nM insulin for 1h, 10 µM Cr(pic)3 for 1h or 12 h or both 
200 nM insulin and 10 µM Cr(pic)3 together for 1h resulted in the increased association of IR 
with relatively-buoyant, detergent-resistant, membrane microdomains (Table 3.2).  Following 
isopycnic sucrose gradient ultracentrifugation of membranes isolated from RBL-2H3 cells 
incubated overnight in serum-free medium prior to Triton X-100 extraction, 2±1% of total IR 
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were associated with buoyant, detergent-resistant fractions (<40% sucrose) and 98±1% of total IR 
were located in the less buoyant bulk membrane (>40% sucrose) (Table 3.2 and Figure 3.2). 
Treatment of RBL-2H3 cells with 200 nM insulin or 10 µM Cr(pic)3 significantly increased IR in 
detergent-resistant fractions. Following exposure to 200 nM insulin, 21±10% of IR were 
associated with detergent-resistant membrane fractions, while 32±8% of IR were localized within 
these fractions after treatment with 10 µM Cr(pic)3.  Simultaneous insulin and Cr(pic)3 treatments 
increased the amount of IR in detergent resistant fractions to 48±3%. Alternatively, pretreatment 
of cells for 1 hr with 10 mM MβCD resulted in only small amounts of IR appearing in detergent-
resistant fractions despite insulin treatment (data not shown).  Interestingly, the distribution of 
phoshorylated IR (pIR) between detergent-resistant and bulk membrane fractions was similar in 
untreated cells and in cells treated with either insulin or Cr(pic)3 (Table 3.2 and Figure 3.2).  
Phosphorylated IRS-1 and phosphorylated AKT associate with detergent-resistant membrane 
microdomains after exposure to insulin or Cr(pic)3 
Overnight incubation of RBL-2H3 cells in serum-free medium resulted in 95% of pIRS-1 
localizing in bulk membrane fractions (Table 3.3). Treatment with 200 nM insulin or 10 μM 
Cr(pic)3 for 1h increased the proportion of  pIRS-1in detergent -resistant fractions from 5±4% to 
62±19% and 58±29%, respectively. Alternatively, treatment of cells with MβCD reduced pIRS-1 
detergent-resistant fraction localization, with 91±1% of pIRS-1 appearing in the bulk membrane 
(Table 3.3). 
Examination of the effects of insulin and Cr(pic)3 suggest that pAKT distributes within the 
plasma membrane and localizes to detergent resistant membrane microdomains in connection 
with the activation of IR signaling (Table 3.3). Treatment of cells with 200 nM insulin for 1 hr 
resulted in 58±13% of pAKT associating with these fractions while 1 h treatment with 10 µM 
Cr(pic)3 resulted in association of 60±7% of pAKT with detergent-resistant fractions. 
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Alternatively, treatment of cells with 10 mM MβCD reduced the amount of pAKT appearing in 
these fractions to 22±9%. 
Cr(pic)3 does not alter insulin receptor surface density or insulin binding capacity 
The effects of Cr(pic)3 on IR surface density and insulin binding capacity were investigated using 
fluorescence correlation spectroscopy.  Equilibrium binding of FITC-insulin to RBL-2H3 cells 
demonstrates that these cells have approximately 100 cell-surface FITC-insulin binding sites μm-2 
(Figure 3.3).  Treatment with Cr(pic)3 did not appear to reduce the number of IR on these cells or 
compete with insulin for binding to available binding sites. However, FITC-insulin binding was 
almost completely blocked by pretreatment for 1 h with 10 μM insulin or overnight incubation in 
medium containing 10% fetal bovine serum, which itself contains insulin and other hormones 
(Figure 3.3).  Thus apparently Cr(pic)3 does not interfere with IR ligand-binding. 
Cr(pic)3 decreases cell surface plasma membrane lipid order 
We investigated the effects of insulin and Cr(pic)3 on RBL-2H3 cell membrane lipid order using 
the small-molecule, phase-sensitive, lipid-probe Di-4-ANEPPDHQ, which exhibits both red-
shifted fluorescence emission and increased fluorescence lifetime as membrane lipid order 
decreases (42-45).  Ratiometric confocal imaging of Di-4-ANEPPDHQ’s two peak emission 
wavelengths (red/green), indicates the relative plasma membrane lipid-order in RBL-2H3 cells, 
either treated with 200 nM insulin or incubated in serum-free medium for over 12 h, are similar. 
This suggests that insulin binding to IR and the accumulation of IR in detergent-resistant 
membrane microdomains has little if any effect on the lipid order of the plasma membrane 
(Figure 3.4). However, treatment of cells with increasing amounts of Cr(pic)3 results in 
significant decreases in RBL-2H3 cell-surface membrane order. Control experiments also 
indicate that depleting membrane cholesterol content using MβCD also significantly decreases 
the order of RBL-2H3 cell plasma membranes (Figure 3.4) (46).   
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Cr(pic)3 localizes to the lipid-water interface in reverse-micelle model membranes 
Decreases in overall plasma membrane order in RBL-2H3 cells in response to short-term 
exposure to Cr(pic)3 suggest a direct interaction between Cr(pic)3 and the lipid bilayer. To address 
this, we examined the effects of Cr(pic)3 on the hydrogen bond network in the aqueous water pool 
of AOT/isooctane RM microemulsions (Table 3.4).  Use of 2.5 % D2O in H2O allows observation 
of the O-D stretch (47) and the effects of Cr(pic)3 on the H-bond network of the ‘water pool’ 
contained within the RM. The size of the water pool affects O-D peak absorption position (48) as 
shown in Table 3.4.  The O-D peak position did not change upon addition of Cr(pic)3 to any of 
the samples examined. Control experiments conducted with the picolinate ligand alone used a 
higher concentration of picolinate compared to those using Cr(pic)3, due to differences in 
molecular size and solubility. However, even these higher concentrations of picolinate did not 
change the O-D peak position. In comparison, previous experiments demonstrate that changes are 
observed in the O-D peak position when using 32 mM decavanadate, a molecule known to reside 
in the water pool of this type of RM microemulsion system (49). These results suggest that 
Cr(pic)3 localizes at, or possibly penetrates, the interfacial region of RM microemulsions and are 
consistent with studies examining the effects of chromium-containing compounds on lipid 
packing in other membrane model systems including, Langmuir monolayers (Audra Sostarecz, 
personal communication). 
Discussion 
Treatment of RBL-2H3 cells with insulin or Cr(pic)3 reduces the average size of cell-surface 
compartments accessed by IR and increases accumulation of IR, pIRS-1 and pAKT within 
detergent-resistant membrane microdomains.  Although the dynamic association of IR or 
downstream targets including IRS-1 and AKT with cholesterol-containing membrane 
microdomains has been demonstrated previously (7, 50), to our knowledge this work is the first to 
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demonstrate association of IR, pIRS-1 and pAKT with nanometer-scale membrane microdomains 
in response to treatment with Cr(pic)3. 
Previous studies have demonstrated that Cr(pic)3 supplementation improves glucose levels in 
insulin-resistant KK/HIJ diabetic mice (15) where it increases pIR numbers without having any 
apparent effect on PTP1B activity (17).  Because of this, it has been proposed that effects of 
Cr(pic)3 result from increased expression of IR and downstream substrates (22).  However, in our 
studies, short term exposure of live cells to Cr(pic)3 for 1 hr or overnight, had no effect on the 
surface density of FITC-insulin binding sites.  This is similar to results obtained by several other 
investigators (15, 17) and, although effects of Cr(pic)3 on unphosphorylated IRS-1 and AKT were 
not examined here, a recent study also demonstrates that total IRS-1 and AKT levels are not 
altered by chromium treatment (17).  This suggests that the increased levels of pIRS-1 and pAKT 
observed in our work resulted from increased activity of pIR in response to insulin or Cr(pic)3 
treatments.   
The mechanism involved in Cr(pic)3 activation of IR appears to be markedly different from that 
of insulin.  Unlike insulin, which interacts directly with IR, our results indicate Cr(pic)3 decreases 
lipid order in a concentration-dependent fashion, as has been reported previously (14, 25).  
Because cholesterol-containing membrane fragments presumably remain intact on Cr(pic)3-
treated cells, the mechanism regulating Cr(pic)3 mediated decreases in membrane lipid order is 
also distinctly different from that of MβCD.  Our results suggest that Cr(pic)3 alters the 
partitioning of IR and downstream substrates in cholesterol-containing membrane microdomains 
and the bulk plasma membrane.  We propose that the general decrease in lipid order of the bulk 
membrane affects the preferential association of membrane proteins, such as IR, with specialized, 
cholesterol-containing membrane microdomains, leading to increased receptor signaling.    
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The relationship between membrane lipid order and activation of IR signaling has previously 
been proposed for other compounds with insulin-like properties.  For instance, IR signaling 
efficacy has been shown to increase with decreased plasma membrane order in isolated rat 
adipocytes, presumably due to increased activation of IR (51), and several groups have suggested 
that the effects of the anti-diabetic drug N,N-dimethylimidodicarbonimidic diamide (Metformin) 
may be related to changes in both cell-surface lipid order and membrane physiology (52-54).  
Reducing plasma membrane order in response to Metformin appears to increase the rate of 
GLUT4 vesicle translocation to the cell-surface (55), perhaps by concentrating IR within 
specialized, cholesterol-containing membrane microdomains.  
Our results also underscore the importance of membrane microdomains as signaling platforms for 
IR function.  Increased association of IR with these microdomains may also increase the 
association of IR with downstream molecules involved in cell signaling.  Disruption of these 
specialized microdomains by depletion of membrane cholesterol and subsequent effects on 
cellular signaling have been demonstrated for a variety of small molecules (56) and 
transmembrane receptors (57, 58), including the IR where cholesterol depletion using MβCD has 
been shown to reduce both GLUT4-dependant glucose uptake and IRS-1 phosphorylation (50).  
In addition to IR, interactions with specialized membrane microdomains have also been shown to 
modulate the signaling of other cell-surface receptors.  This includes apoptosis of T-cell leukemia 
and multiple myeloma cells by raft localized Fas/CD95 receptors in response to Resveratrol (59), 
T-cell antigen signaling (60) and signaling by MHC class II molecules (61). 
Here, we have shown that the activation of IR by insulin in RBL-2H3 cells is accompanied by the 
association of IR, pIRS-1 and pAKT with nanometer-scale membrane microdomains exhibiting 
high buoyancy and increased lipid packing compared to the bulk membrane.  Although these 
microdomains serve as signaling platforms for IR in both insulin and Cr(pic)3 treated cells, the 
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mechanisms involved in accumulation of IR in these microdomains differ.  We have also shown 
that Cr(pic)3 treatment decreases lipid order in the bulk plasma membrane, but have found no 
evidence of direct interaction between Cr(pic)3 and IR.  Taken together, these observations 
suggest that changes in IR compartmentalization and preferred local environment can modulate 
IR activation regardless of whether IR are occupied by ligand.  
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Figure 1: Single particle tracking of individual insulin receptors on live RBL-2H3 cells. A) 
Diffusion coefficients of individual IR conjugated gold particles plotted versus the average size of 
compartments occupied. B) The size distribution of compartments accessed by individual IR.  
Each reported value is the mean and SEM of measurements on 20 individual particles. 
Figure 2: Localization of insulin receptors in various density sucrose fractions after 
isopycnic centrifugation of RBL-2H3 cell membrane fragments . Before exposure to insulin 
or Cr(pic)3, IR appeared in high density sucrose fractions. Treatment with 200 nM insulin or 10 
μM Cr(pic)3 causes redistribution of IR into lower density fractions. Each reported value is the 
mean and SEM for at least 3 individual experiments. To improve clarity not all conditions 
examined are shown 
Figure 3: Insulin receptor surface density on live RBL-2H3 cells as measured by 
fluorescence correlation spectroscopy. Pre-treatment with 10 µM Cr(pic)3 did not reduce the 
number of IR binding sites while pre-treatment with 10 μM insulin or incubation in medium 
supplemented with 10% FBS, reduced binding of FITC-insulin. Each reported value is the mean 
and SD of measurements from at least 14 individual cells.  To improve clarity not all conditions 
examined are shown. 
Figure 4: Fluorometric assessment of live RBL-2H3 cell plasma membrane lipid order. 
Membrane bound Di-4-ANEPPDHQ fluorescence emission at 605nm (red) to that at 530 nm 
(green) increases as lipid order decreases. Compared to RBL-2H3 cells starved of 10% FBS 
overnight, there was a significant increase in the ratio of Di-4ANEPPDHQ fluorescence in cells 
following treatment with 10 μM Cr(pic)3, indicating a decrease in membrane lipid order.  An even 
greater increase in the ratio of Di-4-ANNEPDHQ fluorescence was observed after treatment with 
10 mM MβCD to deplete membrane cholesterol. Alternatively, loading cells with excess 
cholesterol decreased the ratio of Di-4-ANEPPDHQ fluorescence.  Treatment with insulin or 
10% FBS had no effect on the ratio of Di-4-ANEPPDHQ fluorescence. Each reported value is the 
mean and SD of measurements from at least 15 cells. Values marked with a,b,c,d significantly 
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Table 3.1: SPT measurements of gold-labeled IR on live RBL-2H3 cells before and after treatment 
with insulin or Cr(pic)31. 
__________________________________________________________________________ 
 
Treatment  Diffusion Coefficient (10-11cm2s-1)  Compartment Size (nm)2 
 
Untreated   1.17±0.26    233±15  
200 nM insulin (1hr)  0.44±0.43    111±11a 
Cr(pic)3 (overnight)  0.66±0.13    125±12a 
Cr(pic)3 (1hr)   0.41±0.12      89±9a 
Cr(pic)3, insulin (1hr)  0.39±0.08      96±7a 
__________________________________________________________________________ 
1Each reported value is the mean and SEM of measurements on 20 individual particles. 
2Student’s t-test (p < 0.05) indicates values with superscript a are significantly different compared to 




Table 3.2: Percentages of total IR distributed in low-density and high density membrane fractions from 
RBL-2H3 cells following treatment with insulin, with Cr(pic)3 or with both insulin and Cr(pic)3.1 
_______________________________________________________________________________ 
 
Fractions (sucrose %)  Untreated Insulin  Cr(pic)3 2 Insulin, Cr(pic)3 3 
 
Low density (<40%)    2±1  21±10 a  32±8a  48±3b 
High density (>40%)  98±1  79±10 a  68±8a  52±1b 
_______________________________________________________________________________ 
1Reported values are each the mean and SEM for at least 3 individual experiments. 
2Values with the superscript a differ significantly from the value for untreated cells according to a paired 
t-test (p<0.05).  
3Values with superscript b differ significantly from the value for untreated cells according to a paired 
t-test (p<0.001) 
 
Table 3.3: Localization of pIR, pIRS-1 and pAKT in detergent resistant and bulk membrane fractions following treatment with with insulin, with 




Fractions (sucrose %)  Untreated Insulin2  Cr(pic)3 Cr(pic)3, Insulin MβCD3  MβCD/Insulin 
 
pIR 
 Low density (<40%)  45±3  66±11  33±17  67±11   12±14b  45±13 
 High density (>40%)  55±3  35±11  67±17  33±11   88±14  56±13 
 
pIRS-1   
Low density (<40%)  5±4  62±19a  58±29  N.A.   9±1  N.A. 
 High density (>40%)  95±4  39±19a  43±29  N.A.   91±1  N.A. 
 
pAKT  
 Low density (<40%)  25±12  58±13  60±7  N.A.   22±9  N.A. 97  High density (>40%)  75±12  42±13  40±7  N.A.   78±9  N.A. 
_____________________________________________________________________________________________________________________ 
1Each reported value is the  mean and SEM for at least 3 individual experiments. 
2Values with the superscript a differ significantly from the value for untreated cells according to a paired t-test (p<0.05).  
3Values with the superscript b differ significantly from the value for untreated cells according to a paired t-test (p<0.001). 
98 
 
Table 3.4: Absorbance peak wavelengths for the O-D stretch in reverse micelles and reverse micelles  
containing Cr(pic)3 or picolinate ligand using background subtracted FTIR spectroscopy 
________________________________________________________________________ 
 
wo1 No probe (nm)  5mM Cr(pic)3 (nm)2  100mM picolinate (nm)2 
6 2552±1   2552±1  [0.03]   2553±1 [0.55] 
10 2543±1   2543±1 [0.09]   2544±1 [1.1] 
18 2528±1   2528±1 [0.43]   2528±1 [2.9] 
________________________________________________________________________ 
1wo=[H2O]/[AOT]  
2Square brackets indicate the average number of Cr(pic)3 or picolinate molecules, respectively, present in 
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• Binding of ligand to insulin receptors on live cells is multivalent. 
• Treatment with insulin restricts lateral motions of individual insulin receptors on live 
cells. 
• Clustering of ligand-occupied insulin receptors is reduced by disrupting actin filaments.  
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Recent evidence suggests that, after binding of ligand, insulin receptors (IR) interact with 
specialized, cholesterol-containing, membrane microdomains and components of the actin 
cytoskeleton.  Using single particle tracking techniques, we examined how binding of ligand, 
depletion of membrane cholesterol and disruption of actin filaments affect the lateral motions of 
individual quantum dot-labeled native IR on live rat basophilic leukemia 2H3 cells.  We also 
examined the effects of similar treatments on IR clustering and multivalent binding of ligand on 
these cells using both photon counting histogram analysis and polarization homo-fluorescence 
resonance energy transfer imaging.  Our analysis indicates that binding of ligand to IR on these 
cells is multivalent, involving at least two ligand molecules as labeling concentrations approach 1 
μM.  Binding of ligand also reduces lateral diffusion of individual IR and the size of IR-
containing membrane compartments.  However, while both IR lateral diffusion and the size of IR-
containing compartments increase after disrupting actin filaments or depleting membrane 
cholesterol, clustering of ligand-occupied IR is reduced only by disrupting actin filaments or 
fixing cells prior to exposure to ligand and not by depleting membrane cholesterol.  Thus, it 
appears that, although restriction of IR lateral motions on these cells is sensitive to both actin-
filament dynamics and membrane cholesterol content, clustering of ligand-occupied IR primarily 
involves an actin-dependent mechanism. 
 
Keywords: Insulin receptor, photon counting histogram analysis, single particle tracking, 
polarization homo-transfer FRET, membrane microdomain 
 
1. Introduction 
The insulin receptor (IR) is a well-characterized hetero-tetrameric transmembrane 
receptor, consisting of two extracellular α-subunits, containing multiple ligand-binding sites, and 
two largely intracellular β-subunits with both auto- and trans-tyrosine kinase activity [1-6].  
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Binding of ligand to IR α-subunits induces the phosphorylation of each β-subunit by the other, 
increasing the activity of both β-subunits and in vitro IR is known to exhibit complex allosteric 
ligand-binding properties [2-4]. 
Previous work by our group demonstrates that insulin treatment increases association of 
native IR and downstream substrates with detergent-resistant membrane microdomains on 2H3 
rat basophilic leukemia (RBL-2H3) cells [7].  Similar results obtained by other investigators also 
indicate that, in adipocytes, IR preferentially associate with cholesterol-containing membrane 
microdomains [8-13] and that, in muscle cells, insulin treatment induces substantial 
reorganization of sub-surface actin filaments [14].   It has also been suggested that, in some cell 
types, components of the actin cytoskeleton anchor IR in specialized, cholesterol-containing, 
membrane microdomains such as caveolae [15].  However, the nature of these interactions and 
how they affect both lateral motions of IR and IR self-association, i.e. clustering, is not yet 
adequately characterized at the single-molecule level.   
RBL-2H3 cells are well-characterized with respect to activation of the Type I IgE 
receptor (FcεRI) by antigen crosslinking and, similar to results observed for IR on other cell lines, 
activation of FcεRI on these cells results in increased association of FcεRI with specialized, 
cholesterol-containing, membrane microdomains [25-27].  Additionally, both restriction of 
individual FcεRI lateral motions and clustering of crosslinked FcεRI on these cells has also been 
shown to involve interactions with sub-surface actin-filaments [25].   
In the present work, we utilize single particle tracking (SPT) [16-19] to monitor the 
lateral motions of individual quantum dot-labeled IR diffusing on the surface of viable RBL-2H3 
cells.  We also utilize both photon counting histogram analysis (PCH) [20, 21] and polarization 
homo-fluorescence resonance energy transfer (homoFRET) imaging [22-24] to investigate 
multivalent binding of ligand and clustering of ligand-occupied IR on these cells. We define a 
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cluster as a group of receptors that diffuse together or are within homoFRET distance.  However, 
this does not necessarily imply increased physical crosslinking of such receptors. 
Our results indicate that at least two separate FITC-insulin molecules can bind to 
individual IR on the surface of live RBL-2H3 cells as labeling concentrations approach 1 μM, 
leading to increased restriction of individual IR lateral diffusion and a reduction in the size of IR-
containing membrane compartments.  We also demonstrate that clustering of ligand-occupied IR 
on these cells is reduced by disrupting actin-filaments and by fixing cells with paraformaldehyde 
prior to labeling.  Finally, we show that, while depletion of cholesterol from cell membranes does 
not affect IR clustering, it does increase cell-surface IR lateral and rotational diffusion.  Taken 
together, our results suggest that, although clustering of ligand-occupied IR appears to depend 
primarily on actin-filament dynamics, at least a portion of these receptors occupy nanometer-
scale, cholesterol-containing, membrane microdomains. 
 
2. Materials and Methods 
 2.1 Materials  
 RBL-2H3 cells were purchased from ATCC (Manassas, VA).  Insulin, methyl-β-
cyclodextran (MβCD), paraformaldehyde, cytochalasin D and bovine serum albumin (BSA) were 
purchased from Sigma-Aldrich Inc. (St. Louis, MO).  Anti-insulin receptor-β-biotin (C-19) IgG 
was purchased from Santa Cruz Biotech (Santa Cruz, CA).  FITC-insulin and Qdot605 
streptavidin-conjugated quantum dots, were purchased from Invitrogen (Carlsbad, CA).  
Rhodamine 6G (R6G) was purchased from Allied Chemical (Vadodara, Gujarat, India).  
Modified essential medium (MEM) was purchased from Cellgro (Manassas, VA).  Fetal bovine 
serum (FBS) and fungizone were purchased from Gemini (Sacramento, CA).  Sodium fluorescein 
was purchased from Merck (Whitehouse Station, NJ). 
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2.2 Sample preparation 
For SPT, PCH and homoFRET experiments RBL-2H3 cells were seeded onto sterile #1.5 
glass bottom culture dishes, grown to approximately 50% confluence and, unless otherwise 
indicated, incubated in medium without FBS for a minimum of 12 hr before use to remove a 
source of exogenous insulin and other hormones.  In some experiments cells were treated with 
either 40 μg/mL cytochalasin D or 10 mM MβCD, or both cyotchalasin D or MβCD for 1 hr at 37 
C before labeling. 
2.3 PCH of FITC-insulin labeled insulin receptors 
 In FITC-insulin equilibrium binding experiments, cells were incubated in 0.01 nM - 1 
μM FITC-insulin for 30 min, followed by 4 washes.  In competition binding experiments between 
FITC-insulin and insulin, cells were simultaneously incubated in buffer solutions containing 50 
nM FITC-insulin and increasing amounts of insulin for 30 min then washed 4 times.  To measure 
FITC-insulin dissociation, cells were labeled with 10 nM FITC-insulin for 30 min, washed 4 
times and then examined at the times indicated.  To investigate the effects of aqueous insulin on 
FITC-insulin dissociation, cells were labeled with 250 nM FITC-insulin for 30 min, washed 3 
times for 30 sec in 1 mL of buffer and then incubated in 0.025 nM - 25 μM insulin for 30 min and 
washed 3 times.  
PCH experiments were performed using a modified Nikon TE1000 inverted microscope 
equipped with a 100x, 1.25 NA, oil-immersion objective, an Omnichrome Melles-Griot multi-line 
air-cooled argon ion laser, two PerkinElmer single photon counting modules (SPCM-AQR-14), 
an ALV-6010 digital hardware correlator and a Becker and Hickl GmbH PMS-400 multichannel 
correlator as previously described [28].  Based on FCS measurements of aqueous R6G diffusion, 
the 1/e2 radius of the laser excitation beam at the sample in our system was determined to be 241 
nm (data not shown).  In live cell studies, the laser was focused on the apical cell membrane to 
maximize detector count rates and minimize diffusional correlation times as described by Ries 
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and Schwille [29].  Samples were illuminated for approximately 10 sec before collection of data 
to allow for the irreversible photobleaching of immobile particles [30].  Data were then collected 
for 30 sec during which time the average fluorescence from the sample was relatively uniform as 
indicated by the avalanche photodiode signal readouts (data not shown).  For PCH, detected 
photons were accumulated into successive 1 μs counting channels and then rebinned into 9 μs 
channels to improve signal-to-noise. Accumulated photon counts were then simultaneously 
subjected to autocorrelation, pseudo-crosscorrelation and PCH.  Weighted least-squares fitting 
was used to obtain estimates of the average number of particles in the interrogation volume (N), 
the detected photon counts per molecule per sampling time (ε) and the out-of-focus emission ratio 
(F) as previously described [21, 31, 32].  Each PCH value presented, except those in Supplement 
2, represents the result of measurements on 8-10 individual RBL-2H3 cells.  Each PCH values 
presented in Supplement 2 represents a single measurement from an individual cell. 
2.4 Single particle tracking of individual insulin receptors 
Fluorescent quantum dots were used to track the lateral motions of individual IR on the 
surface of live RBL-2H3 cells.  Briefly, viable RBL-2H3 cells were labeled using a slight 
modification of a protocol that minimizes receptor crosslinking [16].  Cells were first labeled with 
anti-IR-β-biotin IgG at 0.1 μg/mL for 30-40 min, washed 3 times for 1 min in 1 mL of buffer, 
labeled with 100 pM Qdot605 streptavidin-conjugated quantum dots for 10 min and then washed 
6 times for 1 min in 1 mL of buffer before imaging.  Wide-field fluorescence images were then 
collected from the apical surface of live cells using a Zeiss Axiovert 200M microscope equipped 
with a 63x 1.2 NA apochromatic water-immersion objective and custom filter sets (Chroma 
Technology; Bellow Falls, VT).  Images were collected every 33 ms for up to 3 minutes at a total 
magnification of 315x with an Andor Ixon EM+ camera resulting in a final pixel size of 
approximately 50 nm.  This was achieved using a Zeiss 2.5x Optovar and a C-mount 2x 
magnifying lens placed in front of the camera.  Image acquisition and determination of individual 
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particle locations were performed with MetaMorph 7.1.6 (Molecular Devices; Sunnyvale, CA).  
Macroscopic lateral diffusion rates and compartment diagonals were determined using custom 
analysis programs.  Blinking of individual IR-bound quantum dot particles, while apparent, did 
not prevent tracking over long periods of time.  The trajectories of individual particles were 
segmented into compartments by calculation of statistical variance in particle position over time 
[17, 19, 27] producing variance plots that exhibited peaks at inter-compartment boundaries.  
These results were analyzed to yield the compartment size and residence time for each particle.  
Effective macroscopic diffusion was calculated as the square of the compartment diagonal 
divided by four times the residence time in the compartment as previously described [33].  SPT 
values shown each reflects measurements of 30-100 total particles on 10-20 individual RBL-2H3 
cells. 
2.5 HomoFRET imaging of FITC-insulin labeled insulin receptors 
 We used homoFRET methods similar to those previously described [34] to examine 
multivalent ligand binding and clustering of ligand-occupied IR.  Data were acquired on 
individual, FITC-insulin labeled RBL-2H3 cells using an Olympus IX-71 microscope equipped 
with a FV300 confocal scanning unit, a 60x, 1.2NA apochromatic water-immersion objective, 
and a polarizing beam splitter to allow simultaneous collection of parallel and perpendicular 
fluorescence.  FITC-insulin was excited with the 488 nm line of an argon ion laser and 
appropriate barrier and dichroic filters were selected for fluorescence emission.  Individual cells 
emitting ring-like fluorescence from FITC-insulin labeling at the plasma membrane were selected 
for imaging.  Sequences of 30 cell images where then obtained as probe molecules were 
photobleached to approximately 10% of their initial average intensity.  Image analysis was 
performed using custom data analysis programs.  Total intensity (s) and fluorescence anisotropy 
(r) were calculated as s=I║ + 2I┴ and r=(I║ - I┴)/s, where I║ and I┴ are fluorescence emission 
polarized parallel and perpendicular, respectively, to the polarization of excitation light [22, 35].  
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FRET efficiencies (E) were estimated from average initial and final r values using the following 
formula: E=(1 - rinitial/rfinal) x 100% [36].  The variance in change in r (Δr) values between 
individual cells was less than the variance of corresponding initial and final r values. This is due 
to irreproducibility in optical positioning that contributes to uncertainty in both rinitial and rfinal, but 
not Δr.  HomoFRET values shown each represent the result of measurements on 25-30 individual 
RBL-2H3 cells. 
2.6 Presentation of Results 
 All values presented except those in Table 3 are the mean ± SD.  Values presented in 
Table 3 are the mean ± SEM. 
 
3. Results 
3.1 PCH of aqueous fluorophores 
(Insert Figure 4.1) 
PCH provides a probability distribution for the number of detected photons observed 
during a specified counting interval and depends on the average photodetection rate for each 
fluorescing species in the system[20, 21, 32].  For each fluorescing species present, PCH is able 
to determine both molecular brightness (ε) and the effective number of particles residing in the 
interrogation volume (N) [37-40].  We utilized PCH to compare the ε of aqueous fluorescein and 
FITC-insulin (Figure 4.1).  Our results demonstrate that the ε of both fluorescein and FITC-
insulin were similar at 0.13±0.01 kHz and that, in solution, the ε of FITC-insulin was constant 
over a 100-fold (1-100 nM) concentration range (data not shown). 
3.2 PCH of FITC-insulin bound to insulin receptors on live-cells  
(Insert Table 4.1) 
(Insert Table 4.2) 
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 We next utilized PCH to examine the ε of IR-bound FITC-insulin molecules on viable 
RBL-2H3 cells.  The increased ε of FITC-insulin molecules when bound to IR diffusing on the 
surface of these cells  relative to when diffusing in solution suggests that either IR separately bind 
at least two ligand molecules as labeling concentrations approach 1 μM  or that binding of ligand 
induces substantial clustering of cell-surface IR.  Equilibrium binding of 10 pM - 1 μM FITC-
insulin shows that as N increased, the ε of detected particles also increased from 0.14±0.01 kHz  
to 0.31±0.07 kHz (Figure 4.1, Table 4.1 and Supplement 4.1).  Treatment of cells with 
cytochalasin D or MβCD before labeling with 1 μM FITC-insulin slightly lowered the ε of 
detected particles to 0.27±0.06 kHz and 0.29±0.04 kHz, respectively, suggesting that the increase 
in ε of FITC-insulin when bound to IR may, in addition to, multivalent binding of ligand also 
reflect clustering of a portion of cell-surface IR via an actin-mediated or cholesterol-dependent 
mechanism.  PCH monitoring the dissociation of FITC-insulin from cells over a 2 hr period 
indicates that the ε of detected particles on cells labeled with 10 nM FITC-insulin decreased from 
approximately 0.18 kHz to 0.14 kHz as N decreased (Supplement 4.2) and the ε of detected 
particles also decreased from 0.26±0.05 kHz to 0.19±0.06 kHz in cells that were labeled with 250 
nM FITC-insulin for 30 min and then incubated in either 50 pM or 50 μM insulin, respectively, 
for 30 min before observation.  Finally, competition binding of 50 nM FITC-insulin and 25 pM - 
25 μM insulin to live cells indicates that the ε of cell-bound FITC-insulin decreased from 
0.25±0.04 kHz to 0.17±0.02 kHz as N decreased (Table 4.2).  Combined, these results indicate 
that, changes in N are mirrored by changes in ε which is consistent with both multivalent binding 
of FITC-insulin to IR and ligand-induced clustering of IR. 
3.3 Lateral diffusion of individual cell-surface insulin receptors 
(Insert Figure 4.2) 
(Insert Table 4.3) 
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PCH results indicate that treatment with 50 nM or greater concentrations of insulin 
results in the occupancy of at least 75% of insulin binding sites on viable RBL-2H3 cells (Table 
4.1 and Supplement 4.1).  With this in mind, we examined the lateral motions of IR on the surface 
of live RBL-2H3 cells before and after treatment with both 50 nM and 250 nM insulin (Figure 4.2 
and Table 4.3).  When anti-IRβ-biotin IgG and streptavidin-conjugated quantum dots were used 
to track the movement of individual IR on serum-starved cells the average macroscopic lateral 
diffusion coefficient was approximately 1x10-10cm2s-1, after treatment with insulin this was 
reduced to approximately 3x10-11cm2s-1 (Figure 4.2 and Table 4.3).  The average size of 
compartments accessed by IR was also reduced from approximately 475 nm in serum-starved 
cells to approximately 250 nm after insulin treatment (Figure 4.2 and Table 4.3).  Treatment of 
cells with either 40 μg/mL cytochalasin D, or 10 mM MβCD for 1 hr increased IR lateral 
diffusion to approximately 2x10-9cm2s-1 and 1x10-9cm2s-1, respectively (Table 4.3) and the size of 
IR-containing membrane compartments to approximately 1 μm and 600 nm, respectively.  The 
increases in IR lateral diffusion and compartment size were almost two-fold greater after 
disrupting actin filaments than after depleting membrane cholesterol content, suggesting that 
restriction of individual cell-surface IR lateral motions is regulated differentially by cholesterol-
containing membrane structures and actin filament-delineated membrane compartments.  
3.4 HomoFRET imaging of FITC-insulin-occupied cell-surface insulin receptors 
(Insert Figure 4.3) 
(Insert Table 4.4) 
We next examined both multivalent binding of ligand and ligand-induced clustering of IR 
using homoFRET imaging.  Similar to PCH, homoFRET is useful for monitoring the 
colocalization of biological molecules on the macromolecular scale (~10nm) [22-24], and can 
yield information on multivalent ligand binding and receptor clustering [34].  HomoFRET 
between neighboring, fluorescent molecules is easily observed by monitoring changes in the 
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anisotropy of fluorescence emission as probe molecules are progressively photobleached [24, 34].  
Analysis of FITC-insulin labeled IR on live, otherwise untreated, RBL-2H3 cells indicates that 
the initial r of receptor bound FITC-insulin is 0.13±0.02 and increases 0.06±0.01 as probe 
molecules are bleached to approximately 10% of their original intensity (Figure 4.3, Table 4.4, 
Supplement 4.3).  Using the method originally developed by Yao and Major [36] we calculate 
that the E of FITC-insulin molecules bound to these cells is 32%.  Extraction of membrane 
cholesterol from cells using MβCD decreased the initial r of FITC-insulin labeled IR to 0.10±0.02 
and decreased the total change in r as probe molecules were bleached to 0.05±0.01. However, the 
E of FITC-insulin labeled IR on these cells was nearly identical to the E of cells that were 
untreated before labeling with FITC-insulin (Table 4.4, Supplement 4.3).  Disruption of actin 
filaments using cytochalasin D decreased the total change in r as probe molecules were bleached 
to 0.04±0.01 and decreased the E of FITC-insulin labeled IR to 21%, but did not reduce initial r 
of FITC-insulin labeled IR (Table 4.4, Supplement 4.3).  Simultaneous treatment of cells with 
MβCD and cytochalasin D reduced both the final r of labeled receptors to 0.15±0.02 and reduced 
the observed efficiency of homoFRET to 20%.  Finally, homoFRET analysis of cells fixed in 4% 
paraformaldehyde for 40 min at 37 C before FITC-insulin labeling of IR shows that the while the 
initial and final r of IR bound FITC-insulin slightly increased, the total change in r during 
bleaching of probe molecules decreased to 0.04±0.01 resulting in an E of 25% (Table 4.4, 
Supplement 4.3).  Fixing cells with paraformaldehyde before labeling presumably reduces ligand-
induced changes in cell-surface IR distribution that would otherwise result from exposure to 
FITC-insulin [41].  This suggests that, in addition to homoFRET resulting from multivalent 
binding of ligand, at least a portion of the homoFRET between IR-bound FITC-insulin molecules 
on live, otherwise untreated, cells is due to ligand-induced clustering of IR not seen in cells fixed 
with paraformaldehyde or treated with cytochalasin D before labeling. 
 




How hierarchical organization of the plasma membrane affects both lateral motions and 
spatial distribution of transmembrane protein receptors is of considerable interest [11, 13-15, 42, 
43].  Therefore, we examined how the interaction of a transmembrane receptor such as IR with 
cholesterol-containing membrane structures and actin filament-delineated membrane 
compartments affected both clustering and lateral motions of IR using a variety of fluorescence-
based biophysical techniques.   
A growing body of evidence suggests that several types of membrane structures and 
microdomains serve as platforms for IR signaling [11-13, 44-48] and that components of the actin 
cytoskeleton anchor IR in microdomains such as caveolae [15].  However, the effects of both 
membrane cholesterol depletion and disruption of actin-filament dynamics on clustering of 
ligand-occupied IR and the restriction of individual IR lateral motions have not been adequately 
described at the single molecule level.   
PCH of FITC-insulin binding to native IR on live RBL-2H3 cells suggests that IR ligand-
binding is multivalent and likely involves at least two FITC-insulin molecules as labeling 
concentrations approach 1 μM.  Multivalent binding is evident when comparing the ε of FITC-
insulin, when in solution, and when bound to IR on the surface of RBL-2H3 cells.  Results of 
competition binding between FITC-insulin and unlabeled insulin, as well as FITC-insulin 
dissociation also suggest multivalent ligand-binding.  It is also possible that the shift in ε 
observed as FITC-insulin molecules bind to live RBL-2H3 cells is the result of ligand-induced 
physical crosslinking of multiple IR, however there is significant evidence, both in vitro and in 
live cells, indicating this does not occur [1-4]. 
Single particle tracking studies of IR lateral diffusion on live cells showed that, before 
insulin treatment, individual IR exhibit pseudo-random lateral diffusion within relatively large 
membrane microdomains. After exposure to insulin, individual IR largely become confined 
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within 100nm-400nm scale microdomains and exhibit significantly reduced lateral diffusion.  
Although SPT studies cannot conclusively determine the mechanisms behind this ligand-induced 
restriction of IR lateral motion, they suggest that both actin-filament dynamics and membrane 
cholesterol content regulate IR lateral motions on RBL-2H3 cells.  These results also seem to 
support previous investigations which indicate that the plasma membrane contains hierarchically-
organized lipid and protein-delineated compartments [17, 42, 49, 50].  
Results of homoFRET imaging of FITC-insulin labeled IR on live cells, and on cells 
fixed with paraformaldehyde before labeling, demonstrate that ligand binding induces a 
measurable degree of IR clustering.  These results also indicate that FITC-insulin binding to IR is 
either multivalent or that a portion of IR on these cells are clustered before exposure to ligand.  
Additionally, the reduction in homoFRET efficiency relative to untreated cells when samples 
were treated with cytochalasin D, but not when treated with MβCD before labeling, suggests that 
ligand-induced clustering of IR on RBL-2H3 cells involves an actin-dependent mechanism and is 
not directly tied to membrane cholesterol content.  This is interesting in light of prior evidence 
indicating that binding of ligand causes preferential association of IR with a variety of 
cholesterol-containing membrane microdomains [8-10] and of literature describing increased 
clustering of cell-surface EGFR after depleting membrane cholesterol [37]. Although it should be 
noted that while not affecting clustering of ligand-occupied IR, depleting membrane cholesterol 
did reduce the apparent initial anisotropy of FITC-insulin labeled IR.  
Taken together, our results indicate that native IR on live RBL-2H3 cells bind at least two 
FITC-insulin molecules at labeling concentrations approaching 1 μM and that binding of ligand 
to these cells results in significant restriction of individual IR lateral motions. Our results also 
indicate that clustering of ligand-occupied IR on these cells involves an actin-dependent 
mechanism and does not depend on retention of IR within cholesterol-containing membrane 
microdomains. 
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Figure 1: Representative PCH of fluorescein derived fluorescent probes in solution and 
on viable RBL-2H3 cells. A) 20 nM fluorescein (solution); ε 0.13, N 18.1, F 0.7, reduced χ2 2.3, 
B) 10 nM FITC-insulin (solution); ε 0.11, N 12.7, F 0.7, reduced χ2 0.15, C) 10 pM FITC-insulin 
(live-cells); ε 0.13, N 3.2, F 0.7, reduced χ2 1.1, D) 1 μM FITC-insulin (live-cells); ε 0.3, N 26.7, 
F 0.7, reduced χ2 1.2. 
 
Figure 2: A) Representative trajectories of quantum dot-labeled IR from a serum-starved 
RBL-2H3 cell and a cell treated with 250 nM insulin. B) Average lateral diffusion vs. average 
compartment diagonal for individual quantum dot labeled IR on serum starved cells or cells 
treated with 250 nM insulin. 
 
Figure 3: Representative graph illustrating the change in anisotropy (○) and total fluorescence 
intensity (●) of IR-bound FITC-insulin molecules during the acquisition of 30 sequential images 
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Table 4.1: PCH of equilibrium binding of FITC-insulin to individual RBL-2H3 cells. 
__________________________________________ 
 
FITC-insulin (nM)        N  ε (kHz)1 
 
         0.01   3.4±1.0 0.14±0.01 
      0.1    4.8±1.7 0.15±0.01 
      1.0    7.9±3.2 0.17±0.02 
    10    8.9±3.2 0.20±0.04 
    25  15.3±3.1 0.24±0.03 
  250  19.8±3.2 0.23±0.02 
1000  23.5±4.4 0.31±0.07 
__________________________________________ 




Table 4.2: PCH of competition binding between 50 nM FITC-insulin and insulin on RBL-2H3 cells. 
_______________________________________________ 
 
Insulin (nM)        N  ε (kHz)1 
 
          0.025  12.6±3.1 0.25±0.04 
          0.25  10.1±4.0 0.24±0.03 
          2.5    8.3±3.6 0.24±0.04 
        25     8.4±4.3 0.22±0.02 
      250     4.0±1.3 0.21±0.02 
    2500     3.9±1.3 0.20±0.02 
  25000     2.4±0.5 0.17±0.02 
_______________________________________________ 




Table 4.3: SPT measurements of quantum dot-labeled IR on live RBL-2H3 cells before and after 
treatment with insulin, cytochalasin D or MβCD. 
________________________________________________________________________________ 
 
Treatment   Macroscopic Diffusion (10-10cm2s-1)  Compartment Diagonal (nm) 
Untreated    1.05±0.40    472±9  
50 nM Insulin    0.34±0.071    239±221 
250 nM Insulin    0.27±0.021    266±111 
40 μg/mL Cytochalasin D  17.1±2.51    984±941 
10 mM MβCD    11.2±1.41    599±462 
________________________________________________________________________________ 
1Student’s t-test (p < 0.01) indicates values are significantly different compared to respective values 
measured on untreated cells. 
2Student’s t-test (p < 0.1) indicates values are significantly different compared to respective value 




Table 4.4: HomoFRET measurements of IR labeled with 1μM FITC-insulin on RBL-2H3 cells. 
____________________________________________________________________ 
 
Treatment   Initial r Final r  Δr  E (%) 
 
Untreated   0.13±0.02 0.19±0.02 0.06±0.01 32 
4% Paraformaldehyde  0.15±0.021 0.20±0.02 0.04±0.011 25 
40μg/mL Cytochalasin D 0.15±0.021 0.19±0.02 0.04±0.011 21 
10mg/mL MβCD  0.10±0.021 0.15±0.021 0.05±0.011 33 
MβCD and Cytochalasin D 0.12±0.01 0.15±0.021 0.03±0.011 20 
____________________________________________________________________ 
1Student’s t-test (p < 0.01) indicates values are significantly different compared to respective values 








Chapter V: Peter W. Winter performed single particle tracking shown in Figure 1, fluorescence 
correlation spectroscopy shown in Figure 3 and fluorometric assessment of live cell lipid order 
shown in Figure 4. 
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We compare the effects of insulin and bis(maltolato)oxovanadium(IV) (BMOV) 
on the lateral motions of individual insulin receptors (IR) and the association of IR, 
phosphorylated IR (pIR) and phosphorylated insulin receptor substrate-1 (pIRS-1) with 
chemically-isolated plasma membrane microdomains on rat basophilic leukemia (RBL-
2H3) cells.  Single particle tracking experiments indicate that individual quantum dot-
labeled IR on live, untreated RBL-2H3 cells exhibit relatively unrestricted lateral 
diffusion of approximately1x10-10 cm2s-1 and are confined in approximately 475 nm size 
cell-surface membrane compartments.  After treatment with either 250 nM insulin or 10 
μM BMOV, IR lateral diffusion and the size of IR-containing membrane compartments is 
significantly reduced.  These treatments also increase the association of IR and pIRS-1 
with low-density, detergent-resistant membrane fragments isolated using isopycnic 
sucrose-gradient centrifugation.  Additionally, confocal fluorescence microscopic 
imaging of live RBL-2H3 cells labeled with the phase-sensitive 
aminonaphthylethenylpyridinium-based dye, Di-4-ANEPPDHQ, indicate that treatment 
with BMOV, but not insulin, decreases cell-surface plasma membrane lipid order and 
fluorescence correlation spectroscopy measurements suggest that BMOV treatment does 
not affect IR surface-density or insulin binding affinity.  Finally, 1H NMR spectroscopy 
of cetyl trimethylammonium bromide (CTAB) micelle model membranes shows that an 
oxidized form of BMOV readily localizes to the lipid-water interface and appears to 
interact directly with CTAB head-groups.  Combined, these results suggest that activation 
of IR signaling by both insulin and BMOV involves increased association of IR with 
specialized, nanoscale membrane microdomains but that the insulin-like activity of 
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BMOV is due to changes in cell-surface membrane lipid order rather than to direct 
interactions with IR. 
 




 A number of vanadium-containing compounds have been shown to exert insulin-
enhancing effects [10], including improvements in both insulin sensitivity and glucose 
homeostasis in animal models of type I [11, 12] and type II [13, 14] diabetes mellitus, as 
well as, in certain diabetic human subjects [15].  Several studies have also shown that, in 
vitro, vanadium compounds can act as potent inhibitors of protein tyrosine phosphatases, 
including protein tyrosine phosphatase 1B (PTP1B) [16, 17].   However, the diverse 
effects of vanadium-containing compounds in vivo, along with evidence of their direct 
interactions with model membranes [18] and effects on both lipid packing and membrane 
composition [19, 20], suggest that these compounds may also interact directly with 
biological membranes.  
Several lines of evidence suggest the importance of specialized membrane 
microdomains in insulin-mediated insulin receptor (IR) signaling [1, 2]. These include 
interactions of IR downstream substrates and regulatory molecules with both resident 
lipid raft proteins such as caveolin [1, 2]  and cholesterol-containing membrane structures 
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[3-8].  It appears that these specialized membrane microdomains facilitate insulin 
signaling by spatially organizing IR and IR signaling molecules and that disruption of 
these structures significantly reduces downstream IR signaling efficacy.  Although, it is 
still not clear exactly how these membrane microdomains function in IR signaling as 
there is some evidence that prolonged localization of IR in  cholesterol-containing 
membrane microdomains can lead to insulin resistance in neuronal cells [9].  
 Here, we have compared the effects of insulin and 
bis(maltolato)oxovanadium(IV) (BMOV) on lateral motions of individual native IR on 
live rat basophilic leukemia (RBL-2H3) cells and on the association of IR, 
phosphorylated IR (pIR), phosphorylated insulin receptor substrate-1 (pIRS-1) with 
chemically-isolated, detergent-resistant plasma membrane microdomains.  Using the 
phase-sensitive aminonaphthylethenylpyridinium-based dye, Di-4-ANEPPDHQ, we also 
compared the effects of insulin and BMOV on live RBL-2H3 cell surface membrane lipid 
order and using fluorescence correlation spectroscopy we examined the effects of BMOV 
on IR surface-density and insulin binding affinity.  Finally, using 1H NMR spectroscopy 
we investigated whether an oxidized form of BMOV interacted directly with amphipathic 
lipids in a simple micelle model membrane system and propose two potential orientations 






2. Materials and Methods 
2.1 Materials 
 Minimum Essential Medium (MEM) with Earle’s Balanced Salts was purchased 
from Thermo Scientific (Logan, Utah).  Fetal bovine serum (FBS) and fungizone were 
purchased from Gemini BioProducts (Woodland, CA).  Insulin from bovine pancreas, 
anti-phospho-insulin receptor (Tyr972) IgG, methyl-β-cyclodextrin (MβCD), FITC-avidin, 
and anti-rabbit-biotin IgG were purchased from Sigma-Aldrich (St. Louis, MO).  Anti-
insulin receptor-β (C-19) IgG, anti-insulin receptor-β-biotin (C-19) IgG, anti-insulin 
receptor-α (N-20) IgG and anti-phospho-IRS-1 (Tyr632) IgG were purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA).  BMOV and oxidized BMOV were synthesized 
and characterized as previously described [21, 22].  Di-4-ANEPPDHQ, and Qdot605-
streptavidin-conjugated quantum dots were purchased from Invitrogen (Carlsbad, CA).  
Complete mini protease inhibitor cocktail tablets were purchased from Roche 
(Indianapolis, IN).  35mm, #1.5 glass bottom petri dishes were purchased from Willco 
Wells (Amsterdam, Netherlands) 
2.2 Cell Lines 
 RBL-2H3 cells were maintained in medium that included MEM supplemented 
with Earle’s Balanced Salts, 10% FBS, 200 mM L-glutamine, 10,000 U/mL penicillin G, 
10 µg/ml streptomycin and 25 μg/ml fungizone.  In some experiments, cells were 
incubated in supplemented MEM without FBS for at least 12-16 hr to remove an 
endogenous source of insulin. 
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2.3 Single particle tracking 
 RBL-2H3 cells were seeded onto sterile Willco Wells #1.5 glass bottom culture 
dishes and grown to 50% confluence.  All labeling was performed in Tyrodes buffer 
containing 0.1% BSA.  In experiments using quantum dots to track individual IR, cells 
were labeled first with anti-IR-β-biotin antibody at 0.2 μg/mL for 30-40 min, washed 3 
times for 1 min in 1mL of buffer and labeled with 100 pM quantum dot probe Qdot605-
streptavidin conjugate for 10 min and then washed at least 6 times for 1 min in 1mL to 
remove unbound probe.  This is modified from accepted protocols for minimizing the 
effects of probe-induced receptor-crosslinking [23].  Wide-field fluorescence images 
were then collected from the apical surface of live cells using a Zeiss Axiovert 200M 
microscope equipped with a 63x 1.2 NA apochromatic water-immersion objective and 
custom filters.  Images were collected every 33 ms for up to 3 min at a total 
magnification of 315x with an Andor Ixon EM+ camera resulting in a final pixel size of 
49.6 nm.  This was achieved using a Zeiss 2.5x Optovar and a C-mount 2x magnifying 
lens placed in front of the camera.  Image acquisition and determination of individual 
particle locations were performed with MetaMorph 7.1.6 (Molecular Devices).  
Macroscopic diffusion rates and compartment diagonals were determined using custom 
analysis programs.  Blinking of individual IR-bound quantum dot particles, while 
apparent, did not prevent tracking over long periods of time.  The trajectories of 
individual particles were segmented into domains by calculation of statistical variance in 
particle position over time [24, 25] producing variance plots that exhibited peaks at inter-
domain boundaries.  These results were analyzed to yield the domain size and residence 
time for each particle.  Effective macroscopic diffusion was calculated as the square of 
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the domain diagonal divided by four times the residence time in the domain as previously 
described [26].  SPT values shown each reflect measurements of 30-100 total particles on 
10-20 individual RBL-2H3 cells. 
2.4 Isolation of plasma membrane fragments 
 RBL-2H3 cells were incubated with 200 nM insulin for 1 hr at 37°C, with 10μM 
BMOV overnight at 37°C or with both 10μM BMOV overnight and 200 nM insulin for 1 
hr at 37°C.  To isolate membrane rafts from RBL-2H3 cells, 5x107 cells were washed two 
times with phosphate-buffered saline, pH 7.4 (PBS) and lysed for 5-10 min on ice in 1 
mL of a buffer containing 25 mM MES, 150 mM NaCl, 2mM EDTA, 0.25% Triton-
X100, and a protease inhibitor cocktail including aprotinin, leupeptin, EDTA, and PMSF.  
A low speed 300x g spin was used to remove cell nuclei and large cell debris.  
Supernatant from this spin which contained plasma membrane fragments, was then 
combined with an equal volume of 80% sucrose containing 0.25% Triton-X100 and 
protease inhibitors to produce a 40% sucrose solution.  A discontinuous sucrose gradient 
from 10-80% was created with the sample in 40% sucrose layered within this gradient.  
The gradient was loaded into a Beckman SW-41 swinging bucket rotor and spun at 
175,000x g for 20 hr at 4°C.  After the spin, eighteen fractions were carefully collected 
from the top of the gradient downward.  A 50 μL aliquot from each fraction was diluted 
1:1 with 95% SDS and 5% β-mercaptoethanol.  After separation of proteins from each 
fraction using SDS-PAGE and transfer of proteins to nitrocellulose, IR was identified 
using anti-IR-β antibody as previously described [27].  Fractions 1-9 contained low 
density membrane fragments and were designated as membrane rafts based on sucrose 
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concentrations of less than 40%, and the presence of the raft-specific marker flotillin 
(data not shown).  In experiments evaluating membrane distributions of pIR and pIRS-1, 
50 μL aliquots from fractions 7-12 were diluted 1:1 with 95% SDS and 5% β-
mercaptoethanol and, after separation of proteins from each fraction using SDS-PAGE 
and transfer of proteins to nitrocellulose, pIR was identified using anti-pIR antibody and 
pIRS-1 was identified using anti-pIRS-1 antibody.  Protein of interest in each fraction 
was determined using a Bio-Rad GS-800 calibrated densitometer.  Sucrose 
concentrations were determined using a Bausch and Lomb refractometer.  In some 
experiments, cells were treated for 1 hr at 37°C with 10 mM MβCD, to deplete 
membrane cholesterol content after incubation with either insulin or BMOV.  Differences 
between treated cells and untreated were evaluated using Student’s paired t-test (p<0.05).   
2.5 Fluorescence correlation spectroscopy 
 RBL-2H3 cells were seeded onto sterile dishes as described above. Prior to some 
FCS experiments, cells were treated with 10 μM excess insulin for 1 hr or 10 μM BMOV 
overnight. Cells were then sequentially washed and labeled with anti-IRα (N-20) rabbit 
IgG (SantaCruz Bio) for 30-40 min, anti-rabbit-biotin IgG (Sigma) for 20 min, and FITC-
avidin for 15 min, washed and then submerged in 1 mL buffer.  Alternatively, cells were 
labeled with FITC-insulin (Invitrogen) and then washed 4 times for 30 secs in 1mL of 
buffer.  FCS experiments were performed on a modified Nikon TE1000 inverted 
microscope equipped with a 100x, 1.25NA, oil-immersion objective, an expanded 
Omnichrome/ Melles-Groit multi-line air-cooled argon ion laser operating at 514.5 nm, 
two 570/32 nm bandpass filters, two Perkin Elmer single photon counting modules 
140 
 
(SPCM-AQR-14) and an ALV-6010 digital hardware correlator as previously described 
[28].  The 1/e2 radius of the excitation beam at the sample was confirmed to be 241 nm 
using aqueous rhodamine-6G (data not shown).  In live cell, studies the laser excitation 
beam was vertically positioned on the apical cell membrane by adjusting the objective z-
position to maximize detector count rates and minimize diffusional correlation times (τD) 
as described by Ries and Schwille [29].  Samples were illuminated for approximately 10 
sec before collection of data to allow for the irreversible photobleaching of immobile 
particles [30].  Data was then collected for two consecutive 10 sec intervals during which 
time the average fluorescence from the sample was relatively uniform as indicated by the 
photodiode signal readouts (data not shown).   Analysis of correlation data, including 
determination of τD and the normalized initial G(τ) were accomplished according to 
established procedures using Igor Pro 5.05A [31-33].   
2.6 Measurement of plasma membrane lipid order  
 RBL-2H3 cells were seeded onto sterile dishes as described above and treated 
with 50 nM or 250 nM insulin for 1hr or with 10μM BMOV overnight.  In some 
experiments, cells were treated with 10mM MβCD for 1hr or loaded with cholesterol or 
7-dehydrocholesterol as previously described [34].  Cells were then labeled with 1μM Di-
4-ANEPPDHQ for 30 minutes, washed and immersed in buffer for imaging.  Confocal 
fluorescence images were acquired using an Olympus IX-71 inverted microscope 
equipped with a 60x, 1.2NA water-immersion objective and a Fluoview 300 confocal 
scanning unit. Cell samples were illuminated with a 488 nm laser.  Fluorescence 
emission, split between detector channels 1 and 2 using a 560 nm dichroic mirror, was 
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collected simultaneously in channel 1 using a 530 nm long-pass filter and in channel 2 
using a 610 nm long-pass filter.  All images were collected at identical instrument and 
detector settings with the exception of the laser excitation power which was adjusted 
between experiments due to slight variations in labeling efficiency.  Background 
correction and fluorescence intensity ratio calculation were performed using NIH Image J 
1.42i. 
2.7 1H NMR spectroscopy of CTAB micelles 
 Micelle samples were prepared from 50 mM CTAB in D2O and 2 mM oxidized 
BMOV, also in D2O. A Varian Inova 400 NMR spectrometer was utilized to obtain 1H 
NMR spectroscopy measurements of the CTAB micelles and deuterated aqueous 
samples.  CTAB micelle samples were referenced with internal DSS standard and 
aqueous stock samples were referenced with external DSS/D2O.  
 
3. Results 
 3.1 Individual insulin receptors exhibit restricted lateral diffusion following treatment 
with insulin or BMOV 
(Insert Figure 5.1) 
 Changes in the lateral motions of cell-surface molecules such as IR are associated 
with ligand-mediated receptor signaling.  We compared the effects of insulin and BMOV 
on the lateral motions of individual IR on the surface of live RBL-2H3 cells (Figure 5.1A 
142 
 
and 5.1B).  When anti-IRβ conjugated fluorescent quantum dots were used to track the 
movement of individual IR on cells treated with either 50 nM or 250 nM insulin, the 
average diffusion coefficient was reduced from approximately 1x10-10cm2s-1 to 
approximately 3x10-11cm2s-1.  Treatment with 10 µM BMOV for 2 or 12 hr also reduced 
the lateral diffusion coefficients of individual IR to approximately 6x10-11cm2s-1.  
Additionally the average size of the compartments accessed by IR was reduced from 
approximately 500 nm to less than 300 nm with insulin treatment and to approximately 
400 nm after exposure to 10 μM BMOV (Figure 5.1B).  
3.2 Insulin receptors and phosphorylated IRS-1 associate with low-density membrane 
microdomains following treatment with insulin or BMOV 
(Insert Figure 5.2) 
(Insert Table 5.1) 
(Insert Table 5.2) 
 Incubation of RBL-2H3 cells overnight in serum-free media containing 10 µM 
BMOV, treatment for 1 hr with 200 nM insulin or treatment with both insulin and BMOV 
resulted in redistribution of IR from high density membrane fractions characteristic of the 
bulk membrane to low density detergent-resistant membrane fractions (Figure 5.2).  
Isopycnic gradient centrifugation of plasma membrane fractions from RBL-2H3 cells 
incubated in serum free medium showed that less than 3% of IR were associated with 
low-density fractions of less than 40% sucrose and that over 97% of IR were localized in 
high-density fractions of greater than 40% sucrose characteristic of the bulk plasma 
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membrane (Table 5.1).  Treatment with 200 nM insulin for 1 hr increased the relative 
number of IR in lower density sucrose fractions to over 21% (Figure 2) and treatment of 
cells with 10 μM BMOV overnight increased the amount of IR in lower density sucrose 
fractions to approximately 26% (Table 5.1).  Similarly, when RBL-2H3 cells were treated 
with 10 μM BMOV for at least 12hr and then with 200 nM insulin for 1 hr, nearly 28% of 
IR were found in low density membrane fractions.  
The overall distribution of pIR in detergent-resistant fractions was not 
significantly affected by 1hr treatment with 250 nM insulin or incubation overnight with 
10 μM BMOV. In fact, the distribution of pIR in low and high density membrane 
fractions was only significantly altered by treatment with 10 mM MβCD  (Table 5.2). 
 In contrast to pIR, both insulin and BMOV treatments significantly increased the 
association of pIRS-1 with membrane fractions.  pIRS-1 detected in low density fractions 
increased from 5% in untreated cells to over 61% after 250 nM insulin treatment and to 
86% after treatment with 10 μM BMOV (Table 5.2).  Incubation of cells for 1 hour in 10 
mM MβCD reduced pIRS-1 in detergent-resistant low density membrane fractions to 
levels that did not differ significantly from untreated cells.   
3.3 Insulin receptor surface density and insulin binding affinity following treatment with 
BMOV 
(Insert Figure 5.3) 
 At least one previous study has reported that vanadium-containing 
peroxovanadates can interact directly with IR and affect insulin binding affinity in vitro 
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[35].  We used FCS to investigate the effects of BMOV on IR cell-surface density and 
insulin binding affinity.  Treatment of RBL-2H3 cells with 10 μM insulin or 10 μM 
BMOV did not affect the apparent surface density of IR on RBL-2H3 cells within the 
interrogation volume using an anti-IRα primary IgG (Figure 5.3A).  In addition, the 
observed binding affinity of FITC-insulin for IR was generally consistent with that 
reported by Zhong et al. [36] who used FCS to investigate the binding of TRITC-insulin 
to receptors on human renal tubular cells.  Treatment with 10 μM BMOV also did not 
appear to affect the number of sites available for insulin binding or the affinity of insulin 
for available IR binding sites (Figure 5.3B).  These data suggest that the insulin-like 
effects of BMOV do not result from direct interactions with IR or insulin and are similar 
to previous studies investigating IR interactions with other vanadium-containing 
compounds [37].  
3.4 Live cell plasma membrane lipid order following treatment with insulin or BMOV 
(Insert Figure 5.4) 
 The use of Di-4-ANEPPDHQ for both the measurement of membrane order and 
the identification of cholesterol enriched domains has only recently been reported [38, 
39]. However, in that time, Di-4-ANEPPDHQ has been shown to be a powerful tool for 
probing membrane lipid order in live cells [40, 41].  We utilized Di-4-ANEPPDHQ to 
investigate the relative extent of lipid order in the plasma membrane of RBL-2H3 cells 
treated with insulin or BMOV. Although quite soluble in water, Di-4ANEPPDHQ also 
readily associates with biological membranes and has a peak emission wavelength that 
depends on the relative order of surrounding molecules.  The ratio, (610 nm/530 nm), of 
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fluorescence emission from Di-4-ANEPPDHQ in cells maintained in serum-starved 
medium and in cell treated with insulin was approximately 0.7 and suggests that insulin 
binding does not alter membrane lipid order (Figure 5.4).  However, the ratio of 
fluorescence emission increased to 0.95 in 10 μM BMOV-treated cells indicating an 
apparent decrease in lipid order and incubation of cells for 1 hr with 10 mM MβCD to 
deplete membrane cholesterol content, increased the ratio of fluorescence emission to 
approximately also 1.3 indicating a decrease in membrane lipid order.  Alternatively, 
loading cells with excess cholesterol caused a small increase in lipid order compared to 
cells grown in serum-containing medium (Figure 5.4).  
3.5 Interaction of oxidized BMOV with CTAB micelles 
(Insert Figure 5.5) 
 To determine if the effects of BMOV on live cell plasma membrane lipid order 
where due to direct interactions between BMOV and amphipathic molecules of the lipid 
biliayer, we examined the interactions of BMOV with CTAB in a simple micelle model 
membrane system.  We compared the 1H NMR spectra of oxidized BMOV in bulk D2O 
to the spectra of oxidized BMOV in CTAB micelles. BMOV is believed to be readily 
oxidized in solution [42, 43] and is suitable for NMR spectral examination.  The 0.1-0.2 
ppm upfield shifts of both Ha and Hb of oxidized BMOV in CTAB micelles compared to 
in D2O indicate penetration into the micelle interface (Figure 5.5A).  This interpretation 
is consistent with previous interpretations of 1H NMR spectra of solute system 
interactions [44, 45].  Figure 5.5B illustrates two potential orientations of the oxidized 
BMOV within the micelle both of which would likely result in a significant reordering of 
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the surrounding lipids and are consistent with the interactions observed here and observed 
previously for a variety of insulin-like vanadium-compounds and lipid molecules in 
Langmuir monolayers (A. Sostarecz, personal communication), micelles [46, 47] and 
reverse micelles [48]. 
 
4. Discussion  
 A growing body of evidence suggests that membrane rafts can serve as signaling 
platforms for cell-surface receptors [49-51] including IR. Our results demonstrate that IR 
redistribute from the bulk membrane into nanoscale plasma membrane microdomains 
with characteristics similar to lipid rafts [52] in response to either insulin or BMOV 
treatment.  The translocation of IR to rafts has previously been described by Vainio et al 
[53] who studied Triton X-100 insolubility of IR in hepatoma cells and found that, after 
insulin treatment, IR was localized within detergent-resistant membrane fragments.  
Additionally, in some cell types, insulin-treated IR can preferentially segregate into 
caveolae, a subset of detergent-resistant lipid rafts containing high levels of caveolins 
[54] and other investigators have shown that phosphorylation of IR and downstream 
targets such as IRS-1 involves interactions with lipid raft-like membrane microdomains 
[55] and that disruption of these structures is associated with insulin resistance [56].   
 While insulin-mediated activation of IR is relatively well-characterized, the 
mechanism for the insulin-like activity of BMOV is less clear.  Vanadium-containing 
compounds are known in vitro inhibitors of protein tyrosine phosphatases [17] and it is 
possible that the activation of IR and IRS-1 seen in our investigations resulted from 
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decreased dephosphorylation of IR by PTP1B.  In fact, vanadate has been shown to 
stimulate tyrosine phosphorylation of IR in rat adipocytes [57], sodium orthovanadate 
reversed the decreased tyrosine phosphorylation of IR in STZ diabetic rats [58] and 
BMOV specifically increased tyrosine phosphorylation of IR [59].  However, the 
inhibition of protein phosphatases by BMOV does not explain either, the effects of 
BMOV on distribution of cell-surface IR, or the apparent effects of BMOV on cell-
surface plasma membrane order.  The question that arises from our results is whether the 
raft localization of IR and inhibition of tyrosine phosphatase activity may both be 
required for the insulin-like effects of BMOV. 
 The importance of cholesterol-containing rafts in receptor-mediated signaling is 
evident from the effects of membrane cholesterol depletion [60, 61].  For example in 
insulin-mediated signaling, insulin-stimulated glucose uptake, down-stream tyrosine 
phosphorylation of both IRS-1and protein kinase B, and insulin-dependent binding of 
IRS-1 to IR were all inhibited when 3T3-L1 adipocytes were treated with MβCD to 
extract membrane cholesterol [62]. Similarly, our results indicate that disruption of 
cholesterol-dependent, membrane microdomains reduced the appearance of pIR and 
pIRS-1 in high-buoyancy membrane compartments.  This behavior would arise if insulin-
mediated IR and IRS-1 activation is most efficient within lipid rafts where higher 
concentrations of associated signaling molecules exist.  BMOV, despite its known 
activity as a PTP1B inhibitor, was not able to counteract the effects of MβCD treatment. 
The disruption of lipid rafts may not, however, completely eliminate IR-mediated signal 
transduction.  As reported by Vainio et al [53], there seems to be some IR and IRS-1 that 
remain within the bulk membrane, albeit at reduced concentrations.  
148 
 
 Unlike insulin, it is clear that BMOV is able to interact with amphipathic lipids in 
model membrane systems and significantly decreases plasma membrane lipid order in 
live cells.  However, the effects of BMOV on membrane order reported here, differ from 
previously reported effects of other vanadium-containing compounds with insulin-like 
activity including  NaVO3, vanadyl acetylacetonate, and vanadium dipciolinate which, in 
isolated erythrocyte membranes, increased membrane order [63]. Although, our results 
are consistent with those of Siddiqui et al [20] who observed decreased membrane lipid 
order after treating alloxan monohydrate-induced diabetic rats with Trigonella and 
sodium orthovanadate.  Our results also support those of Owen et al [64] who used Di-4-
ANEPPDHQ to investigate the effects of temperature and membrane cholesterol content 
on lipid order in live HEK-293 cells.  It appears that, by decreasing lipid order without 
disrupting raft domains, BMOV may alter the preferred environment of cell-surface IR, 
resulting in increased retention of IR in specialized, nanoscale membrane structures and 
the likelihood that IR and downstream substrates, including IRS-1, are activated. 
 Together, our data suggest the involvement of specialized, nanoscale membrane 
microdomains in insulin-mediated IR signaling and suggest that the spatial coordination 
of key signaling proteins, such as IRS-1 within these microdomains provides an efficient 
mechanism for promoting IR signal transduction.   Although association of IR with the 
nanoscale membrane structures observed here appears to be affected by both BMOV and 
insulin, the mechanisms employed by these molecules to initiate IR-mediated signaling 
differ.  While both insulin and BMOV reduce IR lateral diffusion and result in increased 
association of IR and pIRS-1 with specialized, detergent-resistant membrane structures, 
BMOV alone reduces plasma membrane lipid order.  This suggests the insulin-like 
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effects of BMOV are most likely not due to direct interactions with IR or changes in IR 
surface density. Rather, BMOV may be able to interact directly with cell-surface plasma 
membranes, driving changes in lipid order that lead to increased compartmentalization 
and activation of IR and IRS-1. 
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6.  Figure Legends  
Figure 1: Single particle tracking of individual insulin receptors. A. Diffusion coefficients 
from single particle tracking of IR using quantum dots. Both insulin and BMOV 
treatments reduced IR lateral diffusion significantly when compared to untreated serum 
starved cells. Shown are the average values and SEM from at least 20 individual particle 
measurements. B. Values for compartment size from single particle tracking of insulin 
receptors using quantum dots.  Individual values for compartment sizes were calculated 
from particle tracks of insulin receptors before and after treating cells with 250 nM 
insulin or 100 μM BMOV, both treatments caused a reduction in the size of 
compartments accessed by insulin receptors compared to untreated cells. Each point 
shown is the average value and SEM from at least 20 individual particle measurements.  
Values identified by superscripts a, b, or c, were significantly different (p<0.01) using an 
unpaired Student's t-test with two-tailed distribution. 
Figure 2: Insulin receptor membrane raft localization. Western-blot analysis of plasma 
membrane fractions from RBL-2H3 cells shows that before exposure to insulin, IR 
appeared in high density sucrose fractions and that treatment with 200 nM insulin and/or 
10 μM BMOV caused IR redistribution into lower density fractions. Shown are the mean 
and SEM for at least 3 individual experiments. 
Figure 3: Effects of BMOV on insulin receptor cell-surface density and insulin binding 
affinity: A. Fluorescence correlation spectroscopy measurements of the binding of anti-
IRα IgG to live RBL-2H3 cells before or after 1 hr insulin or 12 hr 100 µM BMOV 
treatment showed no apparent change in IR surface density within the 241 nm xy-radius 
interrogation volume. Shown is the mean and S.D. of measurements from at least 10 
individual cells. B. Insulin-FITC equilibrium binding was examined after 12 hr treatment 
with 100 µM BMOV which did not affect the availability of IR binding sites or the 
apparent affinity of insulin-FITC for IR. Exposure of cells to insulin or insulin-containing 
FBS significantly reduced availability of IR binding sites for insulin-FITC. Each point 
shown is the mean and S.D. of measurements from at least 12 individual cells.   
Figure 4: Fluorescence emission of Di-4-ANEPPDHQ labeled RBL-2H3 cell membranes. 
Di-4-ANEPPDHQ fluorescence emission was collected simultaneously at 530 nm and 
610 nm.  Treatment of FBS starved RBL-2H3 cells with insulin appeared to have no 
effect on Di-4-ANEPPDHQ emission, whereas a significant increase in the emission 
ratio, indicating a change in membrane order, was seen following exposure of cells to 100 
μM BMOV.  Incubation of cells with MβCD increased the ratio of fluorescence emission 
to approx. 1.3 while loading cells with excess cholesterol or 7-dehydrocholesterol 
decreased the emission ratio to approx. 0.6. Each point shown is the mean and SD of 
measurements from at least 15 cells. Values with superscripts a, b, c, d were significantly 
different (p<0.01) using an unpaired Students t-test with two-tailed distribution.  
Figure 5: BMOV interaction with CTAB micelles. A. 1H NMR spectra showing the 
interaction of an oxidized form of BMOV with a CTAB micelle model membrane 
system. The upfield shifts of two protons of the oxidized BMOV indicate penetration into 
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the micelle interface. B. Two proposed orientations of oxidized BMOV within the CTAB 
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Table 5.1: Percent of total IR distributed in low density, detergent-resistant and high density, bulk 
membrane fractions following treatment of RBL-2H3 cells with insulin for 1hr, or with BMOV overnight 
or both insulin and BMOV. 
_______________________________________________________________________________ 
 
Fractions (sucrose %)  Untreated Insulin  BMOV1 Insulin, BMOV 1 
 
Low density (<40%)    2±1  21±10 a  26±3a  28±6b 
High density (>40%)  98±1  79±10 a  74±8a  72±1b 
_______________________________________________________________________________ 
 
1Values with the superscript a are different from the value for untreated cells using a paired t-test 
(p<0.05). Values with superscript b are different from the value for untreated cells using a paired 
t-test (p<0.005) 
 
Table 5.2: Localization of pIR, pIRS-1 and pAKT in detergent resistant and bulk membrane fractions following treatment with insulin for 1hr, or 




Fractions (sucrose %)  Untreated Insulin1  BMOV  BMOV, Insulin  MβCD1  MβCD/Insulin 
 
pIR 
 Low density (<40%)  45±3  66±11  36±8  28±7   12±14b  45±13 
 High density (>40%)  55±3  35±11  64±8  72±7   88±14  56±13 
 
pIRS-1   
Low density (<40%)  5±4  62±19a  86±5  N.A.   9±1  N.A. 
 High density (>40%)  95±4  39±19a  14±5  N.A.   91±1  N.A. 
 
____________________________________________________________________________________________________________________ 159  
1Values with the superscript a are different from the value for untreated cells using a paired t-test (p<0.05). Values with the superscript b are 








CHAPTER VI: Peter W. Winter performed all of the experiments presented herein. 
 
Quantum Dot Probes for Single-Molecule Rotation of Cell Surface Proteins 
 
Peter W. Wintera, Deborah A. Roessa and B. George Barisasa 
aColorado State University, Fort Collins, CO, USA 
 
Rotation of membrane proteins is a sensitive measure of their aggregation state and 
interactions. We have investigated the use of asymmetric quantum dots (QD) as non-bleaching 
imaging probes providing orientation-dependent optical signals from individual cell surface 
proteins. A commercial QD emitting at 605 nm measures 10.9 x 5.3 nm and exhibits an initial 
fluorescence anisotropy of 0.11. Calculated rotational correlation times (RCT) for rotations 
about the particle short and long axes, 0.18 μs and 0.12 μs respectively, suggest that this 
nanoparticle can probe μs timescale molecular rotation. These QDs, and the related 655nm 
QDs, conjugated using streptavidin to anti-insulin receptor antibody, are easily visualized 
bound to 2H3 cell insulin receptors (IR). Blinking of spots demonstrates imaging of individual 
QDs. We excite fluorescence from cell-bound QDs with non-polarized illumination and record 
orthogonally-polarized fluorescence images using an image splitter and an EMCCD camera. 
Image pairs are separated and one polarization is corrected for the optical path g-factor and for 
displacement, rotation and dilation relative to the other polarization. Time-dependent 
fluorescence from regions containing individual QDs in image pairs are extracted and the time-
autocorrelation function for polarization fluctuations calculated either from actual polarization 
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or from a combination of auto- and cross-correlations of polarized fluorescence 
intensities. Individual 655 nm QDs exhibit peak polarization fluctuations with an RMS 
amplitude of 0.06. These fluctuations decay over 30-50 ms. Whether this slow decay represents 
hindered rotation of individual IR or results from crosslinking of multiple receptors by single 
QDs remains to be determined. Current work involves exploration of more highly-asymmetric 
QDs, use of faster detection methods and examination of the 2H3 cell Type I Fcε receptor 
where rotational dynamics on faster timescales have previously been explored in detail. 
Supported by NIH grant RR023156 and NSF grant CHE-062826. 
CONCLUSION 
 
 We have described the utilization of a variety of microscopic- and spectroscopic-based 
biophysical techniques to quantitatively examine the motions, interactions and local environment 
of transmembrane proteins on living cells at the single-molecule level. Our studies indicate that 
luteinizing hormone receptors, insulin receptors, insulin-like growth factor type-1 receptors and 
the high affinity IgE receptor all exhibit significant changes in either their motions, interactions 
with other lipids and proteins or local environment after exposure to receptor-specific ligands or 
to reagents that alter membrane composition. We have also shown that often these changes in 
receptor motions and interactions are accompanied by a redistribution of the receptors into or out 
of specialized lipid and cytoskeletal protein delineated membrane microdomains, known to be 
involved in cell signaling. 
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